https://www.nrgoncology.org/Home/News/Post/june-24-2019/ 2019-06-26T13:36:31+00:00 https://www.nrgoncology.org/Home/News/Post/may-20-2019/ 2019-06-26T13:36:59+00:00 https://www.nrgoncology.org/Home/News/Post/april-23-2019/ 2019-06-26T13:37:39+00:00 https://www.nrgoncology.org/Home/News/Post/july-1-2019/ 2019-07-22T18:03:40+00:00 https://www.nrgoncology.org/Home/News/Post/patient-reported-outcomes-upping-the-game-for-pro-methods-and-design-in-clinical-trials/ 2019-07-22T18:06:47+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-sdmc-awarded-nci-funding-for-next-6-years-with-outstanding-score/ 2019-07-22T18:07:35+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-awarded-nci-funding-for-next-6-years-receives-exceptional-score/ 2019-07-22T18:11:16+00:00 https://www.nrgoncology.org/Home/News/Post/project-team-member-application-bay-1895344/ 2019-07-22T18:12:16+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-pilot-projects/ 2019-07-22T18:12:58+00:00 https://www.nrgoncology.org/Home/News/Post/special-edition-july-2019-nrg-meeting/ 2019-08-06T19:08:18+00:00 https://www.nrgoncology.org/Home/News/Post/08-05-2019-weekly-broadcast/ 2019-08-06T19:10:27+00:00 https://www.nrgoncology.org/Home/News/Post/07-26-2019-nrg-gy014/ 2019-08-06T19:11:57+00:00 https://www.nrgoncology.org/Home/News/Post/december-18-2018-join-the-head-and-neck-cancer-alliance-in-celebrating-the-2019-oral-head-and-neck-cancer-awareness-week-april-7-14/ 2019-08-08T17:30:31+00:00 https://www.nrgoncology.org/Home/News/Post/december-17-2018-project-team-member-application-hu5f9-g4/ 2019-08-08T17:33:01+00:00 https://www.nrgoncology.org/Home/News/Post/december-17-2018/ 2019-08-08T17:36:40+00:00 https://www.nrgoncology.org/Home/News/Post/december-13-2018-nctn-and-ncorp-cirb-requirement-policy-implementation-date-effective-march-1-2019/ 2019-08-08T17:45:07+00:00 https://www.nrgoncology.org/Home/News/Post/november-12-2018/ 2019-08-08T17:48:51+00:00 https://www.nrgoncology.org/Home/News/Post/november-5-2018/ 2019-08-08T17:52:17+00:00 https://www.nrgoncology.org/Home/News/Post/september-13-2018-project-team-member-application-ds-8201a/ 2019-08-08T17:53:02+00:00 https://www.nrgoncology.org/Home/News/Post/august-27-2018/ 2019-08-08T17:54:08+00:00 https://www.nrgoncology.org/Home/News/Post/august-23-2018/ 2019-08-08T17:59:23+00:00 https://www.nrgoncology.org/Home/News/Post/july-19-2018/ 2019-08-08T18:01:44+00:00 https://www.nrgoncology.org/Home/News/Post/june-25-2018/ 2019-08-08T18:04:17+00:00 https://www.nrgoncology.org/Home/News/Post/june-25-2018-1/ 2019-08-08T18:05:08+00:00 https://www.nrgoncology.org/Home/News/Post/june-18-2018-an-important-word-from-quality-assurance-about-protocol-amendments/ 2019-08-08T18:08:47+00:00 https://www.nrgoncology.org/Home/News/Post/may-21-2018/ 2019-08-08T18:10:53+00:00 https://www.nrgoncology.org/Home/News/Post/may-7-2018-project-team-member-application-rogaratinib/ 2019-08-08T18:12:29+00:00 https://www.nrgoncology.org/Home/News/Post/april-4-2018-dr-chakravarti-selected-to-serve-on-nci-advisory-board-of-scientific-counselors/ 2019-08-08T18:13:46+00:00 https://www.nrgoncology.org/Home/News/Post/march-30-2018-dr-felix-feng-selected-as-the-new-nrg-oncology-genitourinary-cancer-committee-chair/ 2019-08-08T18:14:26+00:00 https://www.nrgoncology.org/Home/News/Post/march-23-2018/ 2019-08-08T18:15:57+00:00 https://www.nrgoncology.org/Home/News/Post/march-12-2018-project-team-member-application-radium-223/ 2019-08-08T18:17:23+00:00 https://www.nrgoncology.org/Home/News/Post/march-7-2018/ 2019-08-08T18:52:54+00:00 https://www.nrgoncology.org/Home/News/Post/february-19-2018-nrg-oncology-ncorp-pilot-projects/ 2019-08-08T18:55:10+00:00 https://www.nrgoncology.org/Home/News/Post/february-14-2018-nrg-oncology-appoints-ncorp-investigator-matthew-hudson-as-cancer-care-delivery-research-committee-co-chair/ 2019-08-08T18:57:45+00:00 https://www.nrgoncology.org/Home/News/Post/february-13-2018-aghajanian-appointed-as-nrg-oncology-gynecologic-cancer-committee-chair/ 2019-08-08T18:59:04+00:00 https://www.nrgoncology.org/Home/News/Post/february-1-2018-nrg-oncology-appoints-kati-stoermer-for-new-executive-director-role/ 2019-08-08T19:00:08+00:00 https://www.nrgoncology.org/Home/News/Post/november-29-2018-tocagen-and-nrg-oncology-to-collaborate-on-a-phase-23-trial-of-toca-511-toca-fc-in-newly-diagnosed-glioblastoma/ 2019-10-09T19:31:21+00:00 https://www.nrgoncology.org/Home/News/Post/december-6-2018-accelerated-partial-breast-irradiation-although-close-was-not-equivalent-to-whole-breast-irradiation-to-control-ipsilateral-breast-tumor-recurrence/ 2019-10-09T19:46:32+00:00 https://www.nrgoncology.org/Home/News/Post/december-20-2018-time-to-biochemical-failure-could-be-used-as-a-surrogate-endpoint-in-treatment-of-locally-advanced-prostate-cancer/ 2019-10-09T19:49:41+00:00 https://www.nrgoncology.org/Home/News/Post/february-15-2019-nrg-oncology-trial-affirms-hypofractionated-radiotherapy-should-be-considered-new-practice-standard-for-men-with-low-risk-prostate-cancer/ 2019-10-09T19:56:20+00:00 https://www.nrgoncology.org/Home/News/Post/march-12-2019-nrg-oncology-trial-suggests-adding-docetaxel-based-chemotherapy-to-standard-treatment-should-be-considered-for-men-with-high-risk-prostate-cancer/ 2019-10-10T14:35:08+00:00 https://www.nrgoncology.org/Home/News/Post/march-18-2019-prophylactic-cranial-irradiation-improves-disease-free-survival-and-brain-metastasis-rates-for-locally-advanced-non-small-cell-lung-cancer/ 2019-10-10T14:38:34+00:00 https://www.nrgoncology.org/Home/News/Post/june-1-2019-nrg-oncology-trial-shows-tolerability-of-metformin-for-non-small-cell-lung-cancer-no-improvement-in-survival-outcomes-between-treatments/ 2019-10-10T14:42:29+00:00 https://www.nrgoncology.org/Home/News/Post/june-1-2019-initial-experimental-treatment-arm-results-from-nrg-oncology-trial-suggests-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer-is-safe/ 2019-10-10T14:46:37+00:00 https://www.nrgoncology.org/Home/News/Post/june-3-2019-analyses-of-nrg-oncologyrtog-9802-suggests-both-idh-mutant-who-defined-molecular-subgroups-of-high-risk-low-grade-gliomas-may-benefit-from-the-addition-of-pcv-chemotherapy-to-radiotherap/ 2019-10-10T14:51:36+00:00 https://www.nrgoncology.org/Home/News/Post/june-3-2019-nrg-oncology-trial-sets-new-standard-regimen-for-women-with-uterine-carcinosarcomas/ 2019-10-10T14:54:38+00:00 https://www.nrgoncology.org/Home/News/Post/june-3-2019-patients-who-received-partial-breast-irradiation-without-chemotherapy-experienced-less-fatigue-slightly-poorer-cosmesis-on-nrg-oncology-trial/ 2019-10-10T14:58:55+00:00 https://www.nrgoncology.org/Home/News/Post/september-16-2019-pre-salvage-rt-psa-is-predictive-of-hormone-therapy-benefit-with-salvage-rt-for-men-with-recurrent-prostate-cancer-on-nrg-oncology-trial/ 2019-10-10T15:01:55+00:00 https://www.nrgoncology.org/Home/News/Post/september-16-2019-nrg-oncology-trial-shows-no-difference-in-pain-response-between-stereotactic-body-radiotherapy-and-conventional-radiotherapy-for-patients-with-spinal-metastases/ 2019-10-10T15:04:19+00:00 https://www.nrgoncology.org/Home/News/Post/september-16-2019-nrg-oncology-substudy-show-cosmetic-changes-are-equivalent-after-whole-breast-irradiation-versus-partial-breast-irradiation-for-women-with-early-stage-breast-cancer/ 2019-10-10T15:07:29+00:00 https://www.nrgoncology.org/Home/News/Post/september-16-2019-reduced-dose-intensity-modulated-radiotherapy-with-cisplatin-meets-predetermined-benchmarks-for-progression-free-survival-and-swallowing-related-quality-of-life-for-oropharyngeal-c/ 2019-10-10T15:10:57+00:00 https://www.nrgoncology.org/Home/News/Post/september-29-2019-trametinib-improves-outcomes-for-women-with-low-grade-serous-carcinoma-of-the-ovaryperitoneum-on-nrg-oncology-trial/ 2019-10-10T15:28:51+00:00 https://www.nrgoncology.org/Home/News/Post/september-12-2019-nrg-oncology-highlighted-at-astro-2019-with-all-4-astro-plenary-session-talks-featuring-nrg-oncology-research/ 2019-10-10T15:38:14+00:00 https://www.nrgoncology.org/Home/News/Post/september-19-2019-a-letter-from-the-nrg-oncology-group-chairs-on-rare-tumor-trials/ 2019-10-10T15:42:13+00:00 https://www.nrgoncology.org/Home/News/Post/september-19-2019-protocol-support-committee-call-for-applications/ 2019-10-10T15:45:14+00:00 https://www.nrgoncology.org/Home/News/Post/october-10-2019-nrg-oncology-currents-october-2019-enewsletter/ 2019-10-10T15:51:31+00:00 https://www.nrgoncology.org/Home/News/Post/august-8-2019-nrg-cc007cd-re-opened-to-practice/ 2019-10-10T15:54:32+00:00 https://www.nrgoncology.org/Home/News/Post/august-12-2019-weekly-broadcast/ 2019-10-10T15:56:57+00:00 https://www.nrgoncology.org/Home/News/Post/august-14-2019-nrg-gy018-kit-ordering/ 2019-10-10T15:59:50+00:00 https://www.nrgoncology.org/Home/News/Post/extended-letrozole-therapy-improves-disease-free-survival-dfs-in-postmenopausal-women-with-hr-breast-cancer-10-year-results-of-nrg-oncologynsabp-b-42-trial/ 2019-12-12T20:03:26+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-shows-that-standard-of-care-chemoradiation-for-stage-iii-non-small-cell-lung-cancer-is-superior-to-two-tested-alternatives/ 2019-12-18T16:37:55+00:00 https://www.nrgoncology.org/Home/News/Post/breast-conserving-treatment-without-surgery-not-supported-at-this-time-results-of-nrg-oncology-study-br005/ 2019-12-18T16:39:38+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-shows-immunotherapy-is-safe-following-chemoradiotherapy-for-women-with-node-positive-cervical-cancer/ 2020-01-02T15:17:08+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-semiannual-meeting-recap-plenary-session/ 2020-01-22T16:35:40+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-semiannual-meeting-recap-social-media-workshop-and-twitter-1-on-1/ 2020-01-22T16:37:16+00:00 https://www.nrgoncology.org/Home/News/Post/cervical-cancer-awareness-month-highlight-nrg-gog-9929/ 2020-01-22T16:40:57+00:00 https://www.nrgoncology.org/Home/News/Post/cervical-cancer-awareness-month-highlight-nrg-gy017/ 2020-01-22T16:41:49+00:00 https://www.nrgoncology.org/Home/News/Post/protocol-support-committee-column-safe-handling-of-hazardous-drugs/ 2020-01-22T16:49:48+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-lu004-cohort-1-has-completed-accrual/ 2020-01-22T18:01:19+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-is-soliciting-pilot-projects-for-applications-focused-on-nrg-ncorp-cancer-prevention-and-control-cpc-priorities/ 2020-02-14T13:04:08+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-solicits-pilot-projects-addressing-nrg-ncorp-cancer-care-delivery-research-ccdr-priorities/ 2020-02-14T13:06:06+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-shows-hippocampal-avoidance-during-whole-brain-radiotherapy-for-brain-metastases-reduces-risks-of-cognitive-toxicity-and-neurologic-symptoms/ 2020-02-17T14:47:29+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-weekly-broadcast-february-17-2020/ 2020-02-17T16:57:19+00:00 https://www.nrgoncology.org/Home/News/Post/national-cancer-prevention-month/ 2020-02-17T18:24:51+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc008-trial-to-open/ 2020-02-17T18:33:15+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-lu006-testing-the-addition-of-targeted-radiation-therapy-to-surgery-and-the-usual-chemotherapy-treatment-for-stage-i-iiia-malignant-pleural-mesothelioma/ 2020-02-17T18:35:44+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-protocol-development-retreat/ 2020-02-17T18:36:56+00:00 https://www.nrgoncology.org/Home/News/Post/a-memorial-for-dr-janet-wolter-grip/ 2020-02-17T18:40:51+00:00 https://www.nrgoncology.org/Home/News/Post/us-covid-19-update/ 2020-03-09T15:27:50+00:00 https://www.nrgoncology.org/Home/News/Post/the-revised-2020-biqsfp-guidelines-are-available/ 2020-03-09T15:28:28+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-is-seeking-applications-for-travel-awards-to-the-next-nrg-meeting-in-july-2020/ 2020-03-09T15:29:09+00:00 https://www.nrgoncology.org/Home/News/Post/the-impact-of-ctdna-on-the-treatment-of-colon-cancer-the-cobra-trial/ 2020-03-10T13:15:44+00:00 https://www.nrgoncology.org/Home/News/Post/total-neoadjuvant-therapy-in-the-treatment-of-locally-advanced-rectal-cancer/ 2020-03-10T13:16:50+00:00 https://www.nrgoncology.org/Home/News/Post/nctn-disease-diagrams-a-helpful-tool/ 2020-03-10T13:18:08+00:00 https://www.nrgoncology.org/Home/News/Post/intensity-modulated-radiotherapy-improved-patient-reported-outcomes-on-nrg-oncology-clinical-trial/ 2020-03-10T18:05:09+00:00 https://www.nrgoncology.org/Home/News/Post/special-message-from-nrg-oncology-leadership/ 2020-03-12T16:00:38+00:00 https://www.nrgoncology.org/Home/News/Post/nci-requests-letters-of-intent-for-laboratories-to-participate-in-the-nci-combomatch-clinical-trial/ 2020-03-19T17:25:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-leadership-special-message-regarding-covid-19-march-23-2020/ 2020-03-23T16:44:06+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-patient-advocate-committee-chair-dorothy-erlanger/ 2020-03-30T12:05:17+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-leadership-special-message-regarding-covid-19-4132020/ 2020-04-13T14:26:56+00:00 https://www.nrgoncology.org/Home/News/Post/concurrent-chemoradiation-in-cisplatin-ineligible-locoregionally-advanced-head-and-neck-cancer-nrg-hn004/ 2020-04-15T12:13:14+00:00 https://www.nrgoncology.org/Home/News/Post/treatment-de-intensification-for-early-stage-hpv-positive-oropharyngeal-cancer-nrg-hn005/ 2020-04-15T12:17:28+00:00 https://www.nrgoncology.org/Home/News/Post/sentinel-lymph-node-biopsy-in-early-stage-oral-cavity-disease-nrg-hn006/ 2020-04-15T12:19:38+00:00 https://www.nrgoncology.org/Home/News/Post/patient-advocate-perspective-the-importance-of-awareness/ 2020-04-15T12:22:57+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-patient-advocate-committee-chair-dorothy-erlanger-1/ 2020-04-15T12:24:53+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-explores-the-addition-of-novel-hormonal-therapy-agents-to-the-usual-treatment-for-node-positive-prostate-cancer/ 2020-04-15T12:32:14+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-covid-19-update-for-5132020/ 2020-05-13T16:10:27+00:00 https://www.nrgoncology.org/Home/News/Post/does-radiotherapy-improve-outcomes-for-patients-with-resected-who-grade-ii-meningioma-nrg-bn003/ 2020-05-13T16:14:12+00:00 https://www.nrgoncology.org/Home/News/Post/having-a-say-the-endbraincancer-initiative-wants-patient-concerns-reflected-in-national-treatment-guidelines/ 2020-05-13T16:16:12+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-celebrates-nurses-during-the-international-year-of-the-nurse-and-national-nurses-month/ 2020-05-13T16:23:55+00:00 https://www.nrgoncology.org/Home/News/Post/an-overview-of-burnout-syndrome/ 2020-05-13T16:26:25+00:00 https://www.nrgoncology.org/Home/News/Post/project-team-member-application-ipatasertib/ 2020-05-21T17:59:00+00:00 https://www.nrgoncology.org/Home/News/Post/trastuzumab-achieves-slight-reduction-in-recurrence-for-women-with-her2-positive-ductal-carcinoma-in-situ-on-nrg-oncology-trial-nsabp-b-43/ 2020-05-29T15:39:47+00:00 https://www.nrgoncology.org/Home/News/Post/combined-cediranib-and-olaparib-presents-similar-activity-to-standard-of-care-treatment-for-platinum-sensitive-ovarian-cancer/ 2020-05-29T15:46:23+00:00 https://www.nrgoncology.org/Home/News/Post/mtx-based-chemotherapy-combined-with-low-dose-whole-brain-radiotherapy-improves-progression-free-survival-for-patients-with-newly-diagnosed-cns-lymphoma/ 2020-05-29T15:51:49+00:00 https://www.nrgoncology.org/Home/News/Post/trastuzumab-combined-with-trimodality-treatment-does-not-improve-outcomes-for-patients-with-her2-overexpressing-esophageal-cancer-on-nrg-oncology-trial/ 2020-05-29T15:55:48+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-biospecimen-bank-awarded-nci-funding-for-next-6-years-with-exceptional-score/ 2020-06-29T13:31:44+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-oncology-protocol-support-committees-clinical-trials-and-clinical-research-associate-workshops-at-nrg-2020/ 2020-07-16T18:02:25+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-oncology-forte-protocol-workshop-at-nrg-2020/ 2020-07-16T18:35:37+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-oncology-digital-health-symposium-at-nrg-2020/ 2020-07-16T19:38:23+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-town-hall-with-the-nci-director-at-nrg-2020/ 2020-07-17T15:11:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-town-hall-at-nrg-2020/ 2020-07-17T16:55:50+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-general-session-at-nrg-2020/ 2020-07-17T21:09:55+00:00 https://www.nrgoncology.org/Home/News/Post/andre-robidoux-md-long-time-researcher-with-the-nsabp-and-nrg-oncology-dies-in-montreal/ 2020-07-29T18:46:37+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-oncology-sorock-trial-compares-two-surgical-procedures-in-women-with-brca1-mutations-to-assess-risk-reduction-for-ovarian-cancer/ 2020-08-07T13:36:39+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-compares-sentinel-lymph-node-biopsy-to-standard-neck-dissection-for-patients-with-early-stage-oral-cavity-cancer/ 2020-08-07T13:41:17+00:00 https://www.nrgoncology.org/Home/News/Post/dr-bauman-named-co-chair-of-the-nci-cancer-prevention-steering-committee/ 2020-08-07T13:43:40+00:00 https://www.nrgoncology.org/Home/News/Post/calling-all-disease-sites-nrg-gy022-open-for-all-patients-undergoing-carboplatin-treatment/ 2020-08-14T15:27:01+00:00 https://www.nrgoncology.org/Home/News/Post/calling-all-disease-sites-nrg-gy022-is-open-for-any-patient-undergoing-carboplatin-treatment-any-cycle/ 2020-08-20T14:40:05+00:00 https://www.nrgoncology.org/Home/News/Post/comprehensive-genomic-analysis-in-nrg-oncology-rtog-9802/ 2020-08-28T18:40:48+00:00 https://www.nrgoncology.org/Home/News/Post/randomized-phase-iii-trial-of-radiation-therapy-with-or-without-pembrolizumab-for-women-with-high-intermediate-risk-mismatch-repair-deficient-dmmr-endometrioid-endometrial-cancer-nrg-gy020/ 2020-09-14T13:41:26+00:00 https://www.nrgoncology.org/Home/News/Post/a-new-trial-in-localized-high-risk-prostate-cancer-gu009-is-opening-soon/ 2020-09-14T13:54:49+00:00 https://www.nrgoncology.org/Home/News/Post/the-raptor-trial-nrg-lu007-for-extensive-stage-small-cell-lung-cancer/ 2020-09-14T13:59:00+00:00 https://www.nrgoncology.org/Home/News/Post/can-immunotherapy-improve-outcomes-for-patients-with-mgmt-unmethylated-glioblastoma-on-nrg-bn007/ 2020-09-14T14:09:56+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-health-disparities-committee-hdc-update-9142020/ 2020-09-14T14:15:34+00:00 https://www.nrgoncology.org/Home/News/Post/nci-proton-letter-for-nrg-sites/ 2020-09-29T14:15:28+00:00 https://www.nrgoncology.org/Home/News/Post/breast-cancer-awareness-month-why-it-matters/ 2020-10-12T15:19:23+00:00 https://www.nrgoncology.org/Home/News/Post/exploring-the-addition-of-nivolumab-to-platinum-gemcitabine-for-recurrent-or-metastatic-nasopharyngeal-cancer-nrg-hn007/ 2020-10-12T15:21:47+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-bn001-photon-imrt-treatment-group-displays-no-significant-survival-difference-between-arms-for-patients-with-glioblastoma-proton-treatment-group-still-accruing/ 2020-10-24T13:00:39+00:00 https://www.nrgoncology.org/Home/News/Post/updated-results-of-nrg-oncology-trial-display-effectiveness-of-gemcitabine-and-daily-radiation-for-bladder-preservation-in-muscle-invasive-bladder-cancer-patients/ 2020-10-25T15:21:10+00:00 https://www.nrgoncology.org/Home/News/Post/pilot-grant-announcement-for-nrg-ncorp-cancer-prevention-and-control/ 2020-10-26T13:31:05+00:00 https://www.nrgoncology.org/Home/News/Post/pilot-grant-announcement-for-nrg-ncorp-cancer-care-delivery-research/ 2020-10-26T13:37:06+00:00 https://www.nrgoncology.org/Home/News/Post/pilot-grant-announcement-for-nrg-ncorp-health-disparities-research/ 2020-10-26T13:41:17+00:00 https://www.nrgoncology.org/Home/News/Post/metastasis-free-survival-is-a-strong-surrogate-endpoint-for-overall-survival-over-biochemical-failure-for-men-receiving-salvage-radiotherapy-for-recurrent-prostate-cancer/ 2020-10-26T14:11:32+00:00 https://www.nrgoncology.org/Home/News/Post/updated-analysis-of-nrg-rtog-9813-indicates-idh12-mutation-status-is-statistically-associated-with-better-overall-and-progression-free-survival-for-patients-with-anaplastic-astrocytoma/ 2020-10-28T14:54:25+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-on-treatment-for-advanced-endometrial-cancer-chosen-as-editors-choice-in-journal-of-clinical-oncology/ 2020-10-28T15:25:04+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-rtog-0617-validates-ercc12-genotypic-signature-as-a-radiosensitivity-biomarker-for-tumor-and-normal-tissues-in-non-small-cell-lung-cancer-patients/ 2020-10-28T15:37:00+00:00 https://www.nrgoncology.org/Home/News/Post/follow-up-results-on-first-multicenter-trial-to-report-outcomes-of-salvage-low-dose-radiotherapy-brachytherapy-after-external-beam-radiotherapy-for-prostate-cancer/ 2020-10-28T16:09:52+00:00 https://www.nrgoncology.org/Home/News/Post/unique-trial-combines-concurrent-immunotherapy-and-radiation-therapy-to-determine-if-this-treatment-option-improves-survival-outcomes-for-patients-with-limited-stage-small-cell-lung-cancer-nrg-lu005/ 2020-11-10T18:14:28+00:00 https://www.nrgoncology.org/Home/News/Post/adding-peposertib-to-radiotherapy-for-patients-with-advanced-head-and-neck-cancer-who-are-cisplatin-ineligible-nrg-hn008/ 2020-12-11T11:59:34+00:00 https://www.nrgoncology.org/Home/News/Post/2020-winter-holiday-closures/ 2020-12-14T15:12:14+00:00 https://www.nrgoncology.org/Home/News/Post/updated-message-from-nrg-oncology-leadership-on-covid-19/ 2020-12-15T15:10:51+00:00 https://www.nrgoncology.org/Home/News/Post/joan-b-goldberg-mph-approaches-retirement-from-nrg-oncology-and-the-nsabp-foundation/ 2020-12-15T16:17:38+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-elects-two-members-to-its-board-of-directors/ 2021-01-12T13:24:31+00:00 https://www.nrgoncology.org/Home/News/Post/2020-in-review-a-message-from-the-chairs-of-nrg-oncologys-research-strategy-committee/ 2021-01-12T14:04:03+00:00 https://www.nrgoncology.org/Home/News/Post/does-the-addition-of-hippocampal-avoidant-bn009/ 2021-01-12T14:13:18+00:00 https://www.nrgoncology.org/Home/News/Post/de-intensification-and-intensification-treatments-for-high-risk-prostate-cancer-patients-stratified-by-genomic-risk-nrg-gu009/ 2021-01-12T14:19:55+00:00 https://www.nrgoncology.org/Home/News/Post/keeping-a-positive-attitude-as-a-cancer-research-nurse-through-a-global-pandemic/ 2021-01-12T14:31:19+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-determines-total-neoadjuvant-therapy-with-pembrolizumab-and-chemoradiotherapy-is-safe-but-may-not-be-beneficial-for-patients-with-locally-advanced-rectal-cancer/ 2021-01-16T15:58:40+00:00 https://www.nrgoncology.org/Home/News/Post/a-message-from-drs-norman-wolmark-and-robert-mannel/ 2021-01-19T21:20:53+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-health-equity-new-investigator-mentor-program-for-underrepresented-minority-scholars/ 2021-01-20T19:16:02+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-results-show-safety-of-adaptive-radiotherapy-in-non-small-cell-lung-cancer-patients-open-paths-to-future-prospective-studies/ 2021-01-27T17:19:48+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-new-investigator-sessions-at-the-nrg-winter-2021-virtual-meeting/ 2021-01-28T21:45:14+00:00 https://www.nrgoncology.org/Home/News/Post/reduced-dose-radiation-with-cisplatin-improves-outcomes-for-hpv-associated-oropharyngeal-carcinoma-patients-on-nrg-oncology-study-justifies-phase-iii-trial/ 2021-01-29T13:57:52+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-townhall-at-the-nrg-winter-2021-virtual-meeting/ 2021-01-29T21:41:05+00:00 https://www.nrgoncology.org/Home/News/Post/the-general-session-at-the-nrg-winter-2021-virtual-meeting/ 2021-01-29T22:54:16+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-committee-chairs-for-pathology-and-health-disparities-research/ 2021-02-02T15:00:08+00:00 https://www.nrgoncology.org/Home/News/Post/national-cancer-prevention-month-february-2021-newsletter/ 2021-02-11T15:26:49+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc008-trial-now-open-february-2021-newsletter/ 2021-02-11T15:29:14+00:00 https://www.nrgoncology.org/Home/News/Post/recipe-for-success-for-quality-of-life-questionnaire-study-compliance-february-2021-newsletter/ 2021-02-11T15:35:04+00:00 https://www.nrgoncology.org/Home/News/Post/the-first-lady-of-the-united-states-and-nci-leadership-highlight-the-importance-of-ncorp-on-world-cancer-day/ 2021-02-12T15:58:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncologys-practice-changing-study-on-ha-wbrt-plus-memantine-was-among-journal-of-clinical-oncologys-top-5-downloads-in-2020/ 2021-02-18T16:18:48+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-solicits-pilot-projects-addressing-nrg-ncorp-cancer-care-delivery-research-ccdr-priorities-1/ 2021-02-19T15:55:43+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-is-soliciting-pilot-projects-for-applications-focused-on-nrg-ncorp-cancer-prevention-and-control-cpc-priorities-1/ 2021-02-19T15:58:47+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-solicits-pilot-projects-addressing-nrg-ncorp-health-disparities-hdc-research-priorities/ 2021-02-19T16:21:46+00:00 https://www.nrgoncology.org/Home/News/Post/nsabp-b-55olympia-interim-analysis/ 2021-02-19T19:01:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cancer-prevention-committee-seeks-applications-for-chair-of-committee/ 2021-02-23T15:04:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-solicits-pilot-projects-for-applications-biospecimens-clinical-trial-data-from-breast-cancer-prevention-studies/ 2021-02-26T13:51:24+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-board-of-directors-appoints-new-at-large-director/ 2021-03-09T16:34:45+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-hippocampal-avoidant-whole-brain-radiotherapy-to-stereotactic-radiosurgery-for-patients-with-10-or-fewer-brain-metastases-from-small-cell-lung-cancer-nrg-cc009/ 2021-03-09T20:55:56+00:00 https://www.nrgoncology.org/Home/News/Post/implementing-remote-consenting-at-the-university-of-hawaii-cancer-center-a-minorityunderserved-ncorp-site/ 2021-03-09T20:58:45+00:00 https://www.nrgoncology.org/Home/News/Post/the-significance-of-checkpoint-inhibitors-and-mmrmsi-testing-in-metastatic-colorectal-cancer-nrg-gi004swog1610-the-commit-study/ 2021-03-09T21:24:09+00:00 https://www.nrgoncology.org/Home/News/Post/acupuncture-in-oncology/ 2021-04-12T19:38:13+00:00 https://www.nrgoncology.org/Home/News/Post/head-and-neck-cancer-awareness-month/ 2021-04-13T13:00:02+00:00 https://www.nrgoncology.org/Home/News/Post/esophageal-cancer-awareness-month/ 2021-04-13T13:06:19+00:00 https://www.nrgoncology.org/Home/News/Post/stereotactic-body-radiotherapy-to-treat-multiple-metastases/ 2021-04-22T15:06:10+00:00 https://www.nrgoncology.org/Home/News/Post/performance-status-measures-a-little-history/ 2021-05-11T14:34:33+00:00 https://www.nrgoncology.org/Home/News/Post/olympia-study-results-to-be-presented-at-2021-asco-annual-meeting/ 2021-06-03T21:02:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-br007-the-debra-trial/ 2021-06-15T14:22:43+00:00 https://www.nrgoncology.org/Home/News/Post/the-forte-trial/ 2021-06-15T14:36:18+00:00 https://www.nrgoncology.org/Home/News/Post/investigating-deintensification-head-neck-radiation/ 2021-06-15T14:40:53+00:00 https://www.nrgoncology.org/Home/News/Post/gi-committee-members-appointees-nci-task-forces/ 2021-06-15T14:55:50+00:00 https://www.nrgoncology.org/Home/News/Post/navigating-virtual-nrg-oncology-group-meeting/ 2021-06-15T15:07:44+00:00 https://www.nrgoncology.org/Home/News/Post/quynh-le-md-appointed-as-an-nrg-oncology-group-chair/ 2021-06-28T12:15:18+00:00 https://www.nrgoncology.org/Home/News/Post/pathology-and-biospecimen-tips-for-success/ 2021-07-12T19:34:06+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-plenary-session-with-keynote-speaker-dr-philip-e-castle/ 2021-07-22T19:53:50+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-board-of-directors-member-dr-jeff-michalski-named-astro-president-elect/ 2021-08-13T13:51:49+00:00 https://www.nrgoncology.org/Home/News/Post/outstanding-nrg-researcher-to-receive-2021-pa-breast-cancer-coalition-potamkin-prize/ 2021-08-13T13:56:29+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-director-of-administration-meetings-and-exhibits-denise-mackey-retires-after-38-years/ 2021-08-13T14:03:53+00:00 https://www.nrgoncology.org/Home/News/Post/testing-durvalumab-olaparib-and-cediranib-in-women-with-platinum-resistant-recurrent-epithelial-ovarian-cancer-primary-peritoneal-or-fallopian-tube-cancer-nrg-gy023/ 2021-08-13T14:11:57+00:00 https://www.nrgoncology.org/Home/News/Post/assessing-the-maximum-tolerated-dose-and-the-efficacy-of-tocilizumab-and-atezolizumab-in-the-treatment-of-recurrent-glioblastoma-nrg-bn010/ 2021-08-13T14:14:02+00:00 https://www.nrgoncology.org/Home/News/Post/opinion-adoption-of-clinical-research-competencies-can-set-the-stage-for-research-success/ 2021-08-13T14:18:39+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-limited-stage-small-cell-lung-cancer-trial-participant-interviewed-on-his-journey/ 2021-08-13T14:22:20+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-lu001-survival-benefits-not-seen-with-addition-of-metformin-to-concurrent-chemoradiation-in-patients-with-locally-advanced-non-small-cell-lung-cancer/ 2021-08-24T19:20:33+00:00 https://www.nrgoncology.org/Home/News/Post/new-head-neck-cancer-committee-chair/ 2021-08-27T13:20:30+00:00 https://www.nrgoncology.org/Home/News/Post/highlighting-nrg-gynecologic-studies-gynecologic-cancer-awareness-month-sept-2021-newsletter/ 2021-09-14T12:59:28+00:00 https://www.nrgoncology.org/Home/News/Post/ovca-survivors-and-thrivers-make-remarkable-strides-in-research-sept-2021-newsletter/ 2021-09-14T13:07:55+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-health-equity-new-investigator-mentor-program-for-underrepresented-minority-urm-scholars-september-2021-newsletter/ 2021-09-14T13:16:14+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc005-forte-five-or-ten-year-colonoscopy-for-1-2-non-advanced-adenomatous-polyps-september-2021-newsletter/ 2021-09-14T13:24:24+00:00 https://www.nrgoncology.org/Home/News/Post/getting-started-with-radiation-therapy-rt-credentialing-september-2021-newsletter/ 2021-09-14T13:46:35+00:00 https://www.nrgoncology.org/Home/News/Post/breast-radiation-following-lumpectomy-confirmed-to-reduce-incidence-of-ibr-for-good-risk-dcis/ 2021-09-27T14:11:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-launches-forte-a-colorectal-cancer-prevention-clinical-trial/ 2021-10-06T19:10:43+00:00 https://www.nrgoncology.org/Home/News/Post/nsabp-and-rtog-foundations-join-gog-foundation-in-funding-of-the-nrg-oncology-health-equity-new-investigator-mentor-program/ 2021-10-07T15:16:25+00:00 https://www.nrgoncology.org/Home/News/Post/congratulations-to-the-nrg-oncology-members-assigned-to-nci-gastrointestinal-task-forces/ 2021-10-12T14:17:02+00:00 https://www.nrgoncology.org/Home/News/Post/assessing-the-maximum-tolerated-dose-of-amg-232-krt-232-with-concurrent-radiotherapy-in-the-treatment-of-soft-tissue-sarcoma-with-wild-type-p53-gene-nrg-dt001/ 2021-10-12T14:32:46+00:00 https://www.nrgoncology.org/Home/News/Post/the-spaig-award/ 2021-10-12T15:20:33+00:00 https://www.nrgoncology.org/Home/News/Post/stewart-anderson-retires-from-university-of-pittsburgh/ 2021-10-12T15:32:32+00:00 https://www.nrgoncology.org/Home/News/Post/congratulations-to-the-nrg-oncology-ncorp-members-assigned-to-nci-steering-committees/ 2021-10-12T15:38:42+00:00 https://www.nrgoncology.org/Home/News/Post/nci-sponsored-trials-have-added-14-million-years-of-life-for-cancer-patients/ 2021-10-12T15:44:54+00:00 https://www.nrgoncology.org/Home/News/Post/former-gynecologic-oncology-group-co-chair-dr-franco-muggia-dies-at-85/ 2021-10-12T15:48:10+00:00 https://www.nrgoncology.org/Home/News/Post/remote-audits-what-is-working-and-what-is-still-missing/ 2021-10-12T15:51:56+00:00 https://www.nrgoncology.org/Home/News/Post/amendment-to-address-accrual-barriers-for-nrg-br004-is-activated/ 2021-10-12T18:06:48+00:00 https://www.nrgoncology.org/Home/News/Post/heal-initiative-advancing-health-equity-in-pain-management-notify-nrg-by-103121/ 2021-10-14T15:10:25+00:00 https://www.nrgoncology.org/Home/News/Post/total-androgen-suppression-with-dose-escalated-radiotherapy-does-not-improve-overall-survival-in-men-with-intermediate-risk-prostate-cancer-results-highlight-need-for-biomarker-studies/ 2021-10-25T21:52:28+00:00 https://www.nrgoncology.org/Home/News/Post/hypofractionated-post-operative-prostate-bed-radiotherapy-does-not-increase-patient-reported-toxicity-for-men-with-prostate-cancer/ 2021-10-25T22:05:15+00:00 https://www.nrgoncology.org/Home/News/Post/combining-radiotherapy-and-immunotherapy-in-patients-with-extensive-stage-small-cell-lung-cancer-nrg-lu007-the-raptor-trial/ 2021-11-11T16:07:33+00:00 https://www.nrgoncology.org/Home/News/Post/congratulations-to-the-nrg-oncology-members-assigned-to-nci-gastrointestinal-task-forces-1/ 2021-11-11T16:11:56+00:00 https://www.nrgoncology.org/Home/News/Post/congratulations-to-the-nrg-oncology-members-assigned-to-nci-gastrointestinal-task-forces-2/ 2021-11-11T16:14:01+00:00 https://www.nrgoncology.org/Home/News/Post/the-university-of-michigan-t32-in-cancer-care-delivery-accepts-first-cohort-of-pre-and-post-doctoral-scholars/ 2021-11-11T16:16:08+00:00 https://www.nrgoncology.org/Home/News/Post/new-prostate-cancer-study-testing-higher-intensity-treatment-for-patients-with-higher-gene-risk-scores-and-lower-intensity-treatment-for-patients-with-lower-gene-risk-scores-nrg-gu010-the-guidance-tri/ 2021-11-11T16:18:40+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-high-and-low-dose-cisplatin-for-patients-with-locoregionally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-nrg-hn009/ 2021-11-11T16:21:38+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-cc005-forte-trial-has-activated/ 2021-11-11T16:23:57+00:00 https://www.nrgoncology.org/Home/News/Post/background-national-coverage-analysis/ 2021-11-11T16:26:32+00:00 https://www.nrgoncology.org/Home/News/Post/mei-yin-c-polley-phd-re-elected-to-serve-as-the-biostatistician-on-the-nci-head-neck-steering-committee/ 2021-11-11T16:27:52+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-applicants-for-the-veterans-affairsmilitary-treatment-facility-subcommittee-chair-position/ 2021-11-16T19:55:07+00:00 https://www.nrgoncology.org/Home/News/Post/spring-2022-symposium-workshop-precision-medicine-applications-in-radiation-oncology/ 2021-11-22T18:32:20+00:00 https://www.nrgoncology.org/Home/News/Post/machtay-young-investigator-travel-award-winter-2022-nrg-meeting/ 2021-11-23T17:03:37+00:00 https://www.nrgoncology.org/Home/News/Post/annual-call-for-nrg-oncology-administrative-committee-member-applications/ 2021-12-01T12:24:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-non-small-cell-lung-cancer-trial-completed-accrual-to-phase-2-undergoing-data-analysis-to-determine-reopening-for-phase-3/ 2021-12-01T19:01:05+00:00 https://www.nrgoncology.org/Home/News/Post/winter-2021-holiday-hours/ 2021-12-06T12:34:37+00:00 https://www.nrgoncology.org/Home/News/Post/phase-3-node-positive-prostate-cancer-trial-reactivates-following-change-to-experimental-treatment-arm-nrg-gu008-the-innovate-trial/ 2021-12-09T14:05:30+00:00 https://www.nrgoncology.org/Home/News/Post/phase-3-trial-combining-two-alkylating-agents-with-radiotherapy-for-newly-diagnosed-glioblastoma-nrg-bn011/ 2021-12-09T14:07:17+00:00 https://www.nrgoncology.org/Home/News/Post/why-should-we-participate-in-nrg-cc005forte/ 2021-12-09T14:09:30+00:00 https://www.nrgoncology.org/Home/News/Post/get-to-know-the-psc/ 2021-12-09T14:21:48+00:00 https://www.nrgoncology.org/Home/News/Post/bupropion-does-not-improve-sexual-desire-for-female-cancer-survivors-on-nrg-oncology-clinical-study/ 2021-12-10T13:15:23+00:00 https://www.nrgoncology.org/Home/News/Post/barbara-good-phd-to-retire-from-nrg-oncology-and-the-nsabp-foundation/ 2021-12-20T13:19:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-data-concludes-paclitaxel-and-carboplatin-should-be-considered-the-standard-of-care-as-first-line-treatment-for-women-with-uterine-carcinosarcoma/ 2022-01-11T12:53:04+00:00 https://www.nrgoncology.org/Home/News/Post/anti-pd-l1-atezolizumab-as-an-immune-primer-and-concurrently-with-extended-field-chemoradiotherapy-for-node-positive-locally-advanced-cervical-cancer-outcomes-presented-soon-nrg-gy017/ 2022-01-12T17:24:19+00:00 https://www.nrgoncology.org/Home/News/Post/a-message-from-the-chairs-of-nrg-oncologys-research-strategy-committee-2021-the-year-in-review/ 2022-01-12T17:33:22+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc005-forte-amendment-3-is-now-active/ 2022-01-12T17:34:27+00:00 https://www.nrgoncology.org/Home/News/Post/phase-2-double-blinded-trial-combining-oligometastatic-radiotherapy-with-androgen-deprivation-therapy-nrg-gu011/ 2022-01-12T17:36:42+00:00 https://www.nrgoncology.org/Home/News/Post/de-intensification-and-intensification-treatments-for-high-risk-prostate-cancer-patients-stratified-by-genomic-risk-nrg-gu009-the-predict-rt-trial/ 2022-01-12T17:37:58+00:00 https://www.nrgoncology.org/Home/News/Post/moving-research-forward-through-legislative-advocacy/ 2022-01-12T17:42:31+00:00 https://www.nrgoncology.org/Home/News/Post/its-all-in-the-details/ 2022-01-12T17:45:06+00:00 https://www.nrgoncology.org/Home/News/Post/trastuzumab-with-chemoradiation-and-surgery-does-not-improve-outcomes-for-esophageal-cancer-patients-trial-highlights-future-research-opportunities/ 2022-01-21T14:25:00+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-results-indicate-trametinib-should-represent-the-new-standard-of-care-for-women-with-recurrent-low-grade-serous-ovarian-cancer/ 2022-02-03T23:52:00+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-feb-2022-newsletter/ 2022-02-08T15:35:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc008-a-non-randomized-prospective-clinical-trial-comparing-the-non-inferiority-of-salpingectomy-to-salpingo-oophorectomy-to-reduce-the-risk-of-ovarian-cancer-among-brca1-carriers-sorock/ 2022-02-08T15:38:09+00:00 https://www.nrgoncology.org/Home/News/Post/recist-11-criteria-toolkit-a-resource-for-success-in-clinical-trials-with-solid-tumor-evaluation-requirements/ 2022-02-08T15:55:04+00:00 https://www.nrgoncology.org/Home/News/Post/dr-miller-re-elected-as-biostatistician-for-the-nci-uterine-task-force/ 2022-02-08T15:56:32+00:00 https://www.nrgoncology.org/Home/News/Post/first-participant-enrolled-on-forte-nrg-cc005/ 2022-02-09T21:03:12+00:00 https://www.nrgoncology.org/Home/News/Post/the-scientific-session-february-2022/ 2022-02-11T17:10:50+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-surgical-oncology-committee/ 2022-03-07T12:52:03+00:00 https://www.nrgoncology.org/Home/News/Post/project-team-member-application-cbx-12/ 2022-03-08T18:32:00+00:00 https://www.nrgoncology.org/Home/News/Post/the-nrg-gi004swog1610-the-commit-study-may-further-improve-outcomes-in-metastatic-colorectal-cancer-with-deficiency-of-dna-repair-dmmrmsi-h/ 2022-03-08T19:12:29+00:00 https://www.nrgoncology.org/Home/News/Post/coming-attractions-or-recent-additions-in-nrg-colorectal-cancer-research-nrg-gi008/ 2022-03-08T19:15:10+00:00 https://www.nrgoncology.org/Home/News/Post/coming-attractions-or-recent-additions-in-nrg-colorectal-cancer-research-nrg-gi005/ 2022-03-08T19:19:14+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-march-nrg-newsletter/ 2022-03-08T19:21:45+00:00 https://www.nrgoncology.org/Home/News/Post/congratulations-to-the-nrg-oncology-members-assigned-to-nci-gastrointestinal-task-forces-rectalanal-cancers/ 2022-03-08T19:23:43+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2022-winter-meeting-wrap-up/ 2022-03-08T19:25:37+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-co-chair-patient-centered-outcomes-research-committee/ 2022-03-10T16:50:13+00:00 https://www.nrgoncology.org/Home/News/Post/nsabp-the-olympia-trial-press-release/ 2022-03-16T17:25:01+00:00 https://www.nrgoncology.org/Home/News/Post/hrr-mutational-status-prognostic-of-survival-outcomes-in-biomarker-analysis-of-nrg-oncology-trial-for-women-with-platinum-sensitive-ovarian-cancer/ 2022-03-18T23:17:38+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-indicates-using-atezolizumab-with-chemoradiation-is-safe-and-demonstrates-signs-of-immune-activation-in-women-with-cervical-cancer/ 2022-03-18T23:18:31+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-immunotherapy-subcommittee/ 2022-03-22T16:50:21+00:00 https://www.nrgoncology.org/Home/News/Post/implentation-science-for-digital-health-ccdr-webinar/ 2022-03-24T18:40:52+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-applications-for-chair-of-the-nrg-early-career-new-investigators-committee/ 2022-04-08T14:21:32+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-announces-new-veterans-affairs-and-military-treatment-facility-subcommittee-appoints-subcommittee-chairs/ 2022-04-11T17:36:10+00:00 https://www.nrgoncology.org/Home/News/Post/exploring-options-to-potentially-improve-treatment-and-quality-of-life-for-patients-in-two-head-and-neck-cancer-trials/ 2022-04-12T16:36:38+00:00 https://www.nrgoncology.org/Home/News/Post/april-is-national-cancer-control-month-nrg-protocol-support-committee-column/ 2022-04-12T16:52:03+00:00 https://www.nrgoncology.org/Home/News/Post/testing-ctdna-as-a-biomarker-for-adjuvant-therapy-intensity-in-stage-3-colon-cancer-nrg-gi008-the-circulate-us-study/ 2022-04-12T16:55:23+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-nrg-cc005-the-forte-study/ 2022-04-12T17:00:02+00:00 https://www.nrgoncology.org/Home/News/Post/west-valley-ovarian-cancer-alliance-gifts-generous-donation-to-the-nrg-oncology-under-represented-minority-investigator-program/ 2022-04-18T16:19:21+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-is-soliciting-pilot-projects-focused-on-biospecimens-and-clinical-trial-data-breast-cancer-prevention-studies/ 2022-04-27T12:39:08+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-executive-director-is-stepping-down-from-the-position/ 2022-04-29T13:48:31+00:00 https://www.nrgoncology.org/Home/News/Post/priya-rastogi-named-nsabp-foundation-ceo/ 2022-05-09T16:47:19+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-of-photon-versus-proton-therapy-for-patients-with-newly-diagnosed-glioblastoma-completes-accrual/ 2022-05-09T22:10:22+00:00 https://www.nrgoncology.org/Home/News/Post/a-safety-run-in-and-phase-ii-study-evaluating-the-efficacy-safety-and-impact-on-the-tumor-microenvironment-of-the-combination-of-tocilizumab-atezolizumab-and-fractionated-stereotactic-radiotherapy-in/ 2022-05-11T13:23:04+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-bn011-seeks-to-improve-treatment-outcomes-in-a-substantial-subset-of-glioblastoma-patients-with-dual-alkylating-therapy/ 2022-05-11T13:27:29+00:00 https://www.nrgoncology.org/Home/News/Post/upcoming-trial-highlight-studying-stereotactic-radiosurgery-before-versus-after-surgery-for-patients-with-resectable-brain-metastases-nrg-bn012/ 2022-05-11T13:29:44+00:00 https://www.nrgoncology.org/Home/News/Post/a-study-champion-perspective-christina-henson-md/ 2022-05-11T13:33:44+00:00 https://www.nrgoncology.org/Home/News/Post/a-randomized-phase-ii-trial-of-immunotherapy-with-dual-immune-checkpoint-inhibitors-compared-to-anti-pd1-monotherapy-in-patients-with-deficient-mismatch-repair-system-recurrent-endometrial-carcinoma-n/ 2022-05-11T13:36:53+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-nrg-cc005forte-trial-communications/ 2022-05-11T14:03:42+00:00 https://www.nrgoncology.org/Home/News/Post/preparing-for-the-nrg-quality-assurance-audit/ 2022-05-11T14:06:55+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-accepting-applications-for-nrg-meeting-travel-awards-deadline-may-26-2022/ 2022-05-12T14:32:04+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc005-forte-breaking-news-welcome-to-the-forte-education-and-communication-specialist/ 2022-06-08T12:59:37+00:00 https://www.nrgoncology.org/Home/News/Post/the-vision-of-remote-auditing-and-monitoring/ 2022-06-08T13:07:04+00:00 https://www.nrgoncology.org/Home/News/Post/additional-taxane-maintenance-therapy-does-not-successfully-improve-overall-survival-for-women-with-advanced-ovarian-peritoneal-and-tubal-cancers/ 2022-06-28T13:02:27+00:00 https://www.nrgoncology.org/Home/News/Post/joint-final-report-of-phase-iii-trials-demonstrate-positive-outcomes-from-combination-of-pcv-chemotherapy-and-rt-in-patients-with-anaplastic-oligodendroglial-tumors/ 2022-06-28T18:10:36+00:00 https://www.nrgoncology.org/Home/News/Post/psa-based-endpoints-should-not-be-used-as-surrogate-endpoints-for-overall-survival-in-men-with-recurrent-prostate-cancer-at-this-time/ 2022-06-29T13:05:37+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-of-atezolizumab-and-chemoradiation-for-patients-with-limited-stage-small-cell-lung-cancer-completes-accrual/ 2022-07-08T12:29:07+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-accepting-applications-for-radiation-oncology-committee-chair/ 2022-07-12T13:28:36+00:00 https://www.nrgoncology.org/Home/News/Post/join-forte-at-the-nrg-oncology-semiannual-meeting/ 2022-07-13T14:45:36+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-selects-ccdr-pilot-project-awardee/ 2022-07-13T15:56:10+00:00 https://www.nrgoncology.org/Home/News/Post/iacrn-international-association-of-clinical-research-nurses/ 2022-07-13T16:00:39+00:00 https://www.nrgoncology.org/Home/News/Post/adding-stereotactic-radiation-therapy-to-immune-therapy-for-patients-with-advanced-renal-cell-cancer-nrg-gu012-the-samurai-study/ 2022-07-13T17:04:18+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-several-new-committee-chairs-vice-chairs/ 2022-07-19T12:53:02+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-ncorp-trial-of-hippocampal-avoidance-for-small-cell-lung-cancer-patients-receiving-prophylactic-cranial-irradiation-reaches-accrual-goal/ 2022-07-26T15:36:44+00:00 https://www.nrgoncology.org/Home/News/Post/oncology-tube-interviews-asco-2022/ 2022-07-27T12:48:49+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-aimed-to-improve-prostate-cancer-survivor-care-planning-reaches-accrual-goal/ 2022-07-29T12:12:26+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-accepting-applications-for-the-position-of-vice-chair-radiation-oncology-committee/ 2022-08-05T14:54:00+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-natural-language-processing-update/ 2022-08-12T12:21:38+00:00 https://www.nrgoncology.org/Home/News/Post/summer-meeting-2022-protocol-support-committee-psc-wrap-up/ 2022-08-12T12:42:11+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-and-the-gog-foundation-honor-the-life-of-mary-dicey-scroggins/ 2022-08-18T14:40:55+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-accepting-applications-for-the-position-of-vice-chair-ancillary-projects-committee/ 2022-09-12T16:24:43+00:00 https://www.nrgoncology.org/Home/News/Post/testing-the-addition-of-trastuzumab-or-trastuzumabpertuzumab-to-the-usual-chemotherapy-for-her2-positive-uterine-serous-or-carcinosarcoma-nrg-gy026/ 2022-09-15T15:56:25+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-gu009-predict-rt-parallel-phase-iii-randomized-trials-for-high-risk-prostate-cancer-evaluating-de-intensification-for-lower-genomic-risk-and-intensification-of-concurrent-therapy-for-higher-genomi/ 2022-09-15T15:57:31+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-gu011-nrg-promethean-study-of-sabr-with-or-without-relugolix-for-pet-recurrent-oligometastatic-prostate-cancer/ 2022-09-15T15:58:27+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-every-three-week-versus-weekly-cisplatin-with-radiotherapy-for-locoregionally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-nrg-hn009/ 2022-09-15T16:01:45+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-the-addition-of-radiation-before-or-after-surgery-for-patients-with-brain-metastases-nrg-bn012/ 2022-09-15T16:02:37+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-health-equity-fellowship-call-for-applications/ 2022-09-15T16:04:30+00:00 https://www.nrgoncology.org/Home/News/Post/protocol-committee-support-psc-column-no-surprises-billing-act-2022/ 2022-09-15T16:05:43+00:00 https://www.nrgoncology.org/Home/News/Post/in-memoriam-james-lloyd-hoehn-md-facs/ 2022-09-15T16:06:40+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-chair-vice-chair-of-radiation-oncology-committee/ 2022-10-06T16:33:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-br007-debra-a-phase-iii-clinical-trial-evaluating-the-de-escalation-of-breast-radiation-for-a-more-conservative-treatment-of-patients-with-low-risk-hormone-sensitive-node-negative-breast-cancer/ 2022-10-12T16:32:03+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-br008-hero-a-phase-iii-randomized-trial-seeking-to-optimize-use-of-radiotherapy-in-patients-with-early-stage-low-risk-her2-positive-breast-cancer/ 2022-10-12T16:38:27+00:00 https://www.nrgoncology.org/Home/News/Post/assessing-the-impact-of-sentinel-lymph-node-mapping-on-patient-reported-lower-extremity-limb-dysfunction-in-endometrial-cancer-nrg-cc010/ 2022-10-12T16:51:49+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-docetaxel-and-trastuzumab-to-ado-trastuzumab-emtansine-for-her2-positive-salivary-gland-cancer-nrg-hn010/ 2022-10-12T16:54:19+00:00 https://www.nrgoncology.org/Home/News/Post/fortestudy-in-chicago/ 2022-10-12T17:12:24+00:00 https://www.nrgoncology.org/Home/News/Post/the-protocol-support-committee-psc-wants-you/ 2022-10-12T17:19:41+00:00 https://www.nrgoncology.org/Home/News/Post/the-addition-of-stereotactic-body-radiation-therapy-sbrt-to-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma-improves-overall-survival/ 2022-10-24T14:09:32+00:00 https://www.nrgoncology.org/Home/News/Post/three-week-hypo-fractionated-whole-breast-irradiation-wbi-with-concurrent-boost-is-not-inferior-to-conventional-wbi-with-a-sequential-boost-following-lumpectomy-for-patients-with-high-risk-early-stage/ 2022-10-24T18:10:35+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-nrg-hn004-shows-addition-of-durvalumab-to-radiation-does-not-improve-outcomes-over-cetuximab-for-head-neck-squamous-cell-carcinoma-patients-with-a-contraindication-to-cisplatin-high/ 2022-10-24T18:16:19+00:00 https://www.nrgoncology.org/Home/News/Post/multi-modal-artificial-intelligence-models-offer-a-more-accurate-prognostication-method-for-intermediate-to-high-risk-localized-prostate-cancer-than-current-nccn-standard/ 2022-10-24T18:23:36+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-patient-advocate-committee-call-for-candidates/ 2022-11-03T17:18:57+00:00 https://www.nrgoncology.org/Home/News/Post/assessing-the-addition-of-imprint-to-surgery-and-systemic-therapy-for-malignant-pleural-mesothelioma-nrg-lu006/ 2022-11-09T16:27:36+00:00 https://www.nrgoncology.org/Home/News/Post/assessing-sbrt-to-the-primary-tumor-followed-by-conventional-radiation-therapy-with-concurrent-chemotherapy-for-patients-with-locally-advanced-non-small-cell-lung-cancer-nrg-lu008/ 2022-11-09T16:29:52+00:00 https://www.nrgoncology.org/Home/News/Post/fortestudy-is-on-youtube/ 2022-11-09T16:32:02+00:00 https://www.nrgoncology.org/Home/News/Post/dr-jong-h-jeong-joins-nrg-oncology-sdmc/ 2022-11-09T16:34:26+00:00 https://www.nrgoncology.org/Home/News/Post/protocol-support-committee-column-nrg-best-practice-tool/ 2022-11-09T16:37:09+00:00 https://www.nrgoncology.org/Home/News/Post/foundation-accrual-credit-for-nrg-membership-requirements-announcement/ 2022-12-08T03:29:29+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-announces-leadership-of-new-diversity-equity-and-inclusion-committee-new-vice-chair-for-ancillary-projects-committee/ 2022-12-12T14:32:33+00:00 https://www.nrgoncology.org/Home/News/Post/julian-hong-md-ms-steward-of-cancer-care-delivery-research-and-innovation/ 2022-12-12T17:01:50+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-meeting-psc-information/ 2022-12-12T17:08:54+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-holiday-closures-for-2022/ 2022-12-19T15:52:40+00:00 https://www.nrgoncology.org/Home/News/Post/a-message-from-the-nrg-oncology-group-chairs-2022-in-review-and-a-look-ahead/ 2023-01-18T16:08:58+00:00 https://www.nrgoncology.org/Home/News/Post/a-message-from-the-nrg-oncology-research-strategy-committee-chairs-2022-the-year-in-review/ 2023-01-18T16:11:30+00:00 https://www.nrgoncology.org/Home/News/Post/adding-atezolizumab-to-cisplatin-and-radiotherapy-for-node-positive-locally-advanced-cervical-cancer-nrg-gy017/ 2023-01-18T16:14:11+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-innovations-continue-in-cancer-care-delivery-research/ 2023-01-18T16:17:06+00:00 https://www.nrgoncology.org/Home/News/Post/fortestudy-workshop/ 2023-01-18T16:21:31+00:00 https://www.nrgoncology.org/Home/News/Post/set-up-for-success-coordinating-recist-11-a-community-hospital-perspective/ 2023-01-18T16:23:17+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-selects-three-awardees-for-health-equity-fellowship-program/ 2023-02-09T14:44:00+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-participant-travel-allowance/ 2023-02-14T14:45:47+00:00 https://www.nrgoncology.org/Home/News/Post/initial-report-on-establishing-working-groups-within-the-head-and-neck-cancer-committee/ 2023-02-14T14:48:01+00:00 https://www.nrgoncology.org/Home/News/Post/protocol-support-committee-psc-column-nrg-oncology-psc-2023-winter-meeting-wrap-up/ 2023-02-14T14:49:35+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-solicits-pilot-projects-for-nrg-ncorp-cancer-care-delivery-research-ccdr-priorities-1/ 2023-02-15T17:37:37+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-solicits-pilot-projects-for-nrg-ncorp-cancer-prevention-control-cpc-priorities-1/ 2023-02-15T17:40:34+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-ncorp-solicits-pilot-projects-for-nrg-ncorp-health-disparities-research-hdr-priorities-1/ 2023-02-16T18:13:12+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-news-its-colorectal-cancer-awareness-month/ 2023-03-15T15:00:36+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-br008-hero-a-phase-iii-randomized-trial-seeking-to-optimize-use-of-radiotherapy-in-patients-with-early-stage-low-risk-her2-positive-breast-cancer-1/ 2023-03-15T15:16:56+00:00 https://www.nrgoncology.org/Home/News/Post/circulating-tumor-dna-one-of-our-newest-tools-for-managing-solid-tumors/ 2023-03-15T15:22:25+00:00 https://www.nrgoncology.org/Home/News/Post/the-addition-of-gemcitabine-with-cisplatin-and-intensity-modulated-radiation-therapy-improves-outcomes-for-women-with-locally-advanced-vulvar-cancer/ 2023-03-23T15:00:55+00:00 https://www.nrgoncology.org/Home/News/Post/the-utilization-of-atezolizumab-as-a-primer-for-chemoradiation-results-in-promising-immune-system-alterations-for-women-with-locally-advanced-cervical-cancer/ 2023-03-23T15:03:49+00:00 https://www.nrgoncology.org/Home/News/Post/study-identifies-two-promising-molecular-targets-for-drug-development-in-recurrent-and-metastatic-cervical-cancer/ 2023-03-23T15:05:36+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-combined-trial-long-term-results-indicate-that-pathologic-complete-response-is-prognostic-of-outcomes-for-soft-tissue-sarcoma-patients/ 2023-03-31T14:05:08+00:00 https://www.nrgoncology.org/Home/News/Post/surgical-implications-of-ctdna-is-this-the-future-for-colon-cancer/ 2023-04-06T17:18:28+00:00 https://www.nrgoncology.org/Home/News/Post/docetaxel-plus-trastuzumab-versus-ado-trastuzumab-emtansine-for-recurrent-metastatic-or-treatment-naive-unresectable-her2-positive-salivary-gland-cancer-nrg-hn010/ 2023-04-12T11:57:40+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-and-rtog-foundation-integrated-efforts-in-the-head-and-neck-cancer-committee/ 2023-04-12T12:00:32+00:00 https://www.nrgoncology.org/Home/News/Post/pi-perspective-the-journey-of-nrg-gy018/ 2023-04-12T12:04:16+00:00 https://www.nrgoncology.org/Home/News/Post/wvoca-donates-additional-funds-to-the-nrg-oncology-health-equity-fellowship-program/ 2023-04-12T12:05:58+00:00 https://www.nrgoncology.org/Home/News/Post/fulvestrant-and-binimetinib-targeted-treatment-for-nf1-mutation-in-hormone-receptor-positive-metastatic-breast-cancer-eay191-n2-a-combomatch-treatment-trial/ 2023-04-12T12:07:51+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-selumetinib-and-olaparib-to-selumetinib-alone-for-ovarian-and-endometrial-cancers-with-ras-pathway-mutations-eay191-n4-a-combomatch-treatment-trial/ 2023-04-12T12:09:10+00:00 https://www.nrgoncology.org/Home/News/Post/forte-at-nrg2023/ 2023-04-12T12:12:11+00:00 https://www.nrgoncology.org/Home/News/Post/show-me-the-money/ 2023-04-12T12:13:13+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-results-confirm-conventional-external-beam-radiotherapy-should-remain-standard-of-care-in-treating-localized-vertebral-metastases-of-the-spine/ 2023-04-27T15:22:35+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-does-not-improve-overall-survival-but-shows-improvements-in-several-clinical-outcomes-for-men-with-intermediate-risk-prostate-cancer/ 2023-04-28T01:20:12+00:00 https://www.nrgoncology.org/Home/News/Post/should-srs-be-delivered-before-or-after-surgery-for-patients-with-brain-metastases-nrg-bn012/ 2023-05-10T12:56:24+00:00 https://www.nrgoncology.org/Home/News/Post/phase-iii-trial-of-stereotactic-radiosurgery-srs-versus-hippocampal-avoidant-whole-brain-radiotherapy-ha-wbrt-for-10-or-fewer-brain-metastases-from-small-cell-lung-cancer-nrg-cc009/ 2023-05-10T12:58:01+00:00 https://www.nrgoncology.org/Home/News/Post/not-leaving-veterans-behind/ 2023-05-10T13:02:23+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-forte-has-accrued-over-550-participants-11-activated-sites-accrued-participants-in-april-2023/ 2023-05-10T13:05:11+00:00 https://www.nrgoncology.org/Home/News/Post/spotlight-on-the-psc-working-groups/ 2023-05-10T13:49:20+00:00 https://www.nrgoncology.org/Home/News/Post/introducing-sdmc-statistics-division-member-eric-polley-phd/ 2023-05-10T13:51:58+00:00 https://www.nrgoncology.org/Home/News/Post/through-a-joint-project-and-on-common-ground-a-large-number-of-investigators-from-us-trial-groups-and-the-national-cancer-institute-reached-consensus-on-issues-regarding-the-strength-of-pre-clinical-d/ 2023-06-08T14:28:00+00:00 https://www.nrgoncology.org/Home/News/Post/breaking-impossible/ 2023-06-09T12:33:51+00:00 https://www.nrgoncology.org/Home/News/Post/sbrt-to-the-primary-tumor-followed-by-conventional-radiation-therapy-and-chemotherapy-for-patients-with-locally-advanced-non-small-cell-lung-cancer-nrg-lu008/ 2023-06-09T12:38:53+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-stereotactic-radiosurgery-to-hippocampal-avoidant-whole-brain-radiotherapy-for-patients-with-high-brain-metastasis-velocity-at-distant-brain-relapse-following-stereotactic-radiosurgery-nrg-b/ 2023-06-09T12:41:08+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-awards-11-fellows-for-the-early-career-new-investigator-mentored-fellowship-program/ 2023-06-09T12:47:17+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-june-2023/ 2023-06-09T12:50:02+00:00 https://www.nrgoncology.org/Home/News/Post/psc-at-the-nrg-2023-summer-meeting/ 2023-06-09T12:53:50+00:00 https://www.nrgoncology.org/Home/News/Post/addition-of-ebrt-to-brachytherapy-did-not-improve-outcomes-for-men-with-intermediate-risk-prostate-cancer-brachytherapy-alone-remains-standard-of-care/ 2023-06-15T13:36:32+00:00 https://www.nrgoncology.org/Home/News/Post/life-as-an-adolescent-young-adult-cancer-survivor/ 2023-07-14T14:05:10+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-july-2023/ 2023-07-14T14:11:58+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-announces-new-leadership-of-the-organizations-cancer-prevention-control-committee-immunotherapy-subcommittee-and-publications-committee/ 2023-07-21T16:07:07+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-honors-dr-walter-wally-curran-as-first-nrg-oncology-gold-medalist/ 2023-07-21T18:39:14+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-august-2023/ 2023-08-11T17:17:13+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2023-summer-meeting-wrap-up/ 2023-08-11T17:22:56+00:00 https://www.nrgoncology.org/Home/News/Post/secondary-analysis-of-nrg-oncology-rtog-0617-presented-at-iaslc-2023/ 2023-09-12T13:11:56+00:00 https://www.nrgoncology.org/Home/News/Post/reminder-to-review-ctep-iam-account-and-nrg-roster-status/ 2023-09-13T13:52:56+00:00 https://www.nrgoncology.org/Home/News/Post/pharmaceutical-management-branch-pmb-aurora-updates/ 2023-09-13T14:04:03+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-september-2023/ 2023-09-13T14:08:27+00:00 https://www.nrgoncology.org/Home/News/Post/rtog-1308-accrual-completion/ 2023-10-03T18:42:42+00:00 https://www.nrgoncology.org/Home/News/Post/breast-cancer-awareness-nrgbr009-ofset/ 2023-10-16T14:59:25+00:00 https://www.nrgoncology.org/Home/News/Post/megan-mullins-ccdr-researcher/ 2023-10-16T15:35:34+00:00 https://www.nrgoncology.org/Home/News/Post/informed-consent-guidance-now-available/ 2023-10-16T15:39:54+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-october/ 2023-10-16T15:46:15+00:00 https://www.nrgoncology.org/Home/News/Post/graboyes-named-hdc-vice-chair/ 2023-10-24T15:57:32+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-accrues-1000-participants/ 2023-11-09T17:12:49+00:00 https://www.nrgoncology.org/Home/News/Post/national-family-caregivers-month/ 2023-11-13T16:16:58+00:00 https://www.nrgoncology.org/Home/News/Post/pancreatic-cancer-awareness-month/ 2023-11-13T16:19:31+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-november-2023/ 2023-11-13T16:24:44+00:00 https://www.nrgoncology.org/Home/News/Post/adverse-event-reporting/ 2023-11-13T16:27:46+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-br008-hero-study-press-release-december-2023/ 2023-12-05T22:09:23+00:00 https://www.nrgoncology.org/Home/News/Post/honoring-a-legacy-dr-worta-mccaskill-stevens/ 2023-12-11T16:31:25+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-pcor-educational-session-at-nrg2024-in-orlando/ 2023-12-11T16:33:07+00:00 https://www.nrgoncology.org/Home/News/Post/the-high-five-trial-for-high-risk-prostate-cancer-activates-nrg-gu013/ 2023-12-11T17:07:50+00:00 https://www.nrgoncology.org/Home/News/Post/managing-data-and-query-expectation-in-nci-research-studies/ 2023-12-11T17:12:55+00:00 https://www.nrgoncology.org/Home/News/Post/annual-message-from-the-nrg-oncology-group-chairs/ 2024-01-16T17:25:21+00:00 https://www.nrgoncology.org/Home/News/Post/cervical-cancer-awareness-month/ 2024-01-16T17:29:01+00:00 https://www.nrgoncology.org/Home/News/Post/psc-continuing-education-sessions-at-nrg2024/ 2024-01-16T17:32:57+00:00 https://www.nrgoncology.org/Home/News/Post/the-forte-workshop-is-coming-soon/ 2024-01-16T17:34:54+00:00 https://www.nrgoncology.org/Home/News/Post/a-message-from-the-chairs-of-nrg-oncologys-research-strategy-committee/ 2024-01-17T13:38:51+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-selects-health-equity-fellows-for-2024/ 2024-02-02T16:04:25+00:00 https://www.nrgoncology.org/Home/News/Post/machine-learning-model-predicts-oxaliplatin-benefit/ 2024-02-06T20:20:24+00:00 https://www.nrgoncology.org/Home/News/Post/pi-interview-the-nrg-cc008-sorock-study-comparing-two-surgical-procedures-for-women-with-brca1-mutations-to-assess-risk-reduction-for-ovarian-cancer/ 2024-02-12T17:23:45+00:00 https://www.nrgoncology.org/Home/News/Post/pi-interview-the-nrg-cc010-study-for-sln-mapping-on-patient-reported-lower-extremity-limb-dysfunction-in-endometrial-cancer/ 2024-02-12T17:26:49+00:00 https://www.nrgoncology.org/Home/News/Post/forte-national-cancer-prevention-month-2024/ 2024-02-12T19:08:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-activates-phase-ii-study-for-ar-positive-ovarian-granulosa-cell-tumors-nrg-gy033/ 2024-02-12T19:09:29+00:00 https://www.nrgoncology.org/Home/News/Post/trial-adding-relatlimab-to-immunotherapy-for-recurrent-or-metastatic-nasopharyngeal-cancer-activates-nrg-hn011/ 2024-02-12T19:24:38+00:00 https://www.nrgoncology.org/Home/News/Post/protocol-support-committee-column-addressing-diversity-in-clinical-trials/ 2024-02-12T19:27:37+00:00 https://www.nrgoncology.org/Home/News/Post/legacy-of-dr-edith-mitchell/ 2024-02-12T21:31:42+00:00 https://www.nrgoncology.org/Home/News/Post/seeking-applications-for-biqsfp-funding-for-non-real-time-integrated-studies-for-nctn-ncorp-trials/ 2024-02-22T18:16:38+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-announces-new-leadership-of-canadian-members-subcommittee/ 2024-02-27T15:32:32+00:00 https://www.nrgoncology.org/Home/News/Post/protocol-support-committee-nrg2024-winter-meeting-wrap-up/ 2024-03-11T16:44:45+00:00 https://www.nrgoncology.org/Home/News/Post/trials-in-progress-update-the-commit-study-nrg-gi004swog-s1610/ 2024-03-11T16:52:47+00:00 https://www.nrgoncology.org/Home/News/Post/trials-in-progress-update-circulate-north-america-nrg-gi008/ 2024-03-11T16:55:05+00:00 https://www.nrgoncology.org/Home/News/Post/trials-in-progress-the-janus-rectal-cancer-trial/ 2024-03-11T17:04:00+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc005-forte-at-nrg2024/ 2024-03-11T17:23:10+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc011-march-2024-newsletter/ 2024-03-11T17:28:10+00:00 https://www.nrgoncology.org/Home/News/Post/hypofractioned-post-prostatectomy-radiotherapy-new-acceptable-practice-standard-based-on-nrg-oncology-trial-findings/ 2024-03-14T15:21:25+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-announces-new-leadership-of-cancer-prevention-control-committee/ 2024-04-03T14:17:20+00:00 https://www.nrgoncology.org/Home/News/Post/trial-in-development-feature-nrg-hn012/ 2024-04-10T16:02:46+00:00 https://www.nrgoncology.org/Home/News/Post/trial-in-development-feature-nrg-hn014/ 2024-04-10T16:03:26+00:00 https://www.nrgoncology.org/Home/News/Post/lost-in-the-shuffle-navigating-patient-follow-up-in-clinical-trials/ 2024-04-10T16:06:03+00:00 https://www.nrgoncology.org/Home/News/Post/forte-updates-april-2024/ 2024-04-10T16:08:45+00:00 https://www.nrgoncology.org/Home/News/Post/danielle-enserro-phd-appointed-the-associate-director-of-biostatistics-and-statistical-programming/ 2024-04-10T16:10:04+00:00 https://www.nrgoncology.org/Home/News/Post/summary-of-research-results-for-nrg-oncology-study-participants/ 2024-05-14T14:16:41+00:00 https://www.nrgoncology.org/Home/News/Post/leveraging-veteran-data-for-the-benefit-of-veteran-cancer-patients/ 2024-05-14T14:22:55+00:00 https://www.nrgoncology.org/Home/News/Post/guidance-on-the-re-consenting-process/ 2024-05-14T14:28:24+00:00 https://www.nrgoncology.org/Home/News/Post/patient-reported-outcomes-compliance-improvement/ 2024-05-14T14:33:58+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-well-positions-affiliated-scholars-to-compete-for-the-most-elite-federal-funding-opportunities/ 2024-05-14T14:41:57+00:00 https://www.nrgoncology.org/Home/News/Post/forte-update-for-may-2024-newsletter/ 2024-05-14T14:44:24+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-announces-new-leadership-of-three-committees/ 2024-05-16T15:53:15+00:00 https://www.nrgoncology.org/Home/News/Post/nsabp-foundation-nrg-oncology-biospecimen-bank-pgh-relocates-to-nova-place-campus/ 2024-05-22T20:42:23+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-vice-chairs-for-their-patient-advocate-committee/ 2024-05-28T14:12:08+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-abstract-considered-best-of-asco-for-2024-shows-difference-in-outcomes-for-node-negative-versus-node-positive-pancreatic-cancer-patients-when-adding-chemoradiation-to-systemic-therapy/ 2024-06-04T17:57:16+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-publication-demonstrates-radiotherapy-should-remain-standard-of-care-future-research-should-consider-tumor-subsets/ 2024-06-13T15:08:56+00:00 https://www.nrgoncology.org/Home/News/Post/advancing-research-nrg-advocates-call-to-action-for-uterine-cancer-awareness-month-and-national-cancer-survivors-month/ 2024-06-13T15:21:55+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc012cd-opens-to-accrual-addressing-patient-symptom-monitoring-and-management/ 2024-06-13T16:30:37+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-june-2024-newsletter/ 2024-06-13T16:32:20+00:00 https://www.nrgoncology.org/Home/News/Post/psc-at-the-nrg-2024-summer-meeting/ 2024-06-13T16:32:56+00:00 https://www.nrgoncology.org/Home/News/Post/nrgs-data-monitoring-committee-through-the-lens-of-an-advocate/ 2024-07-10T11:20:15+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-cancer-no-one-is-immune/ 2024-07-10T11:26:17+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc011-cognitive-training-for-cancer-related-cognitive-impairment-in-breast-cancer-survivors/ 2024-07-10T11:29:59+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-july-2024-newsletter/ 2024-07-10T11:32:44+00:00 https://www.nrgoncology.org/Home/News/Post/mei-yin-polley-phd-promoted-to-full-professor-at-the-university-of-chicago/ 2024-07-10T11:35:34+00:00 https://www.nrgoncology.org/Home/News/Post/lessons-learned-with-lauries-journey-the-importance-of-explaining-clinical-trials-as-an-option-to-patients/ 2024-08-12T16:51:35+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-awards-10-fellows-for-the-early-career-new-investigator-mentored-fellowship-program/ 2024-08-12T16:54:21+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2024-summer-meeting-wrap-up/ 2024-08-12T16:59:06+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-august-2024/ 2024-08-12T17:07:22+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-results-indicate-that-radiation-and-chemotherapy-after-surgery-could-be-a-viable-alternative-to-radical-cystectomy-for-patients-with-recurrent-bladder-cancer/ 2024-09-06T17:12:28+00:00 https://www.nrgoncology.org/Home/News/Post/my-hereditary-cancer-journey-looking-back-look-forward/ 2024-09-11T14:40:46+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-cancer-dtl-overview/ 2024-09-11T14:44:34+00:00 https://www.nrgoncology.org/Home/News/Post/comparing-stereotactic-radiosurgery-to-fractionated-stereotactic-radiosurgery-for-patients-with-cancer-that-has-spread-to-the-brain-nrg-bn013/ 2024-09-11T14:50:37+00:00 https://www.nrgoncology.org/Home/News/Post/adding-stereotactic-radiation-therapy-to-immune-therapy-for-patients-with-advanced-renal-cell-cancer-nrg-gu012-the-samurai-study-1/ 2024-09-11T14:54:03+00:00 https://www.nrgoncology.org/Home/News/Post/pi-interview-the-commit-study-of-immunotherapy-for-dmmr-metastatic-colorectal-cancer-nrg-gi004swog-s1610/ 2024-09-11T14:57:28+00:00 https://www.nrgoncology.org/Home/News/Post/ncorp-pilot-project-awardees/ 2024-09-11T15:01:50+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-september-2024/ 2024-09-11T15:04:19+00:00 https://www.nrgoncology.org/Home/News/Post/quality-of-life-outcomes-reported-from-nrg-oncology-trial-studying-whole-breast-irradiation-vs-accelerated-partial-breast-irradiation-after-breast-conserving-surgery/ 2024-09-16T12:05:55+00:00 https://www.nrgoncology.org/Home/News/Post/cancer-cooperative-group-leaders-propose-a-re-engineering-of-the-nations-correlative-science-program-for-cancer/ 2024-09-18T21:40:56+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-supports-radiotherapy-and-cisplatin-should-remain-the-standard-of-care-for-p16-oropharyngeal-cancer/ 2024-09-30T18:47:51+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-implies-the-addition-of-atezolizumab-concurrently-to-standard-of-care-does-not-improve-survival-in-limited-stage-small-cell-lung-cancer/ 2024-09-30T18:48:55+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-aya-cancer-diagnosis/ 2024-10-09T17:53:33+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-interview-with-laurel-pracht/ 2024-10-09T17:59:11+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-october-2024/ 2024-10-09T18:10:34+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-optional-specimen-collection/ 2024-11-11T16:27:18+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-lu008-november-2024-newsletter/ 2024-11-11T16:31:59+00:00 https://www.nrgoncology.org/Home/News/Post/moving-anti-her2-therapy-into-the-peri-operative-setting-for-locally-advanced-esophagogastric-cancer/ 2024-11-11T16:35:12+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-gu011-promethean-november-2024-newsletter/ 2024-11-11T16:37:16+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-november-2024/ 2024-11-11T16:39:45+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-improving-the-cancer-clinical-trial-matching-ecosystem/ 2024-11-11T16:42:18+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-lifes-a-journey-travel-well/ 2024-11-11T19:26:01+00:00 https://www.nrgoncology.org/Home/News/Post/dr-joan-walker-pivots-from-nrg-ncorp-leadership-role-to-focus-on-mentorship/ 2024-11-21T16:01:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-reaffirms-standard-of-cetuximab-and-radiation-for-patients-with-locoregionally-advanced-head-and-neck-cancer-and-a-contraindication-to-cisplatin/ 2024-11-26T03:17:22+00:00 https://www.nrgoncology.org/Home/News/Post/dr-lisa-kachnic-named-nrg-oncology-ncorp-co-principal-investigator/ 2024-12-10T18:34:19+00:00 https://www.nrgoncology.org/Home/News/Post/legacy-tribute-in-honor-of-felix-feng-md/ 2024-12-11T23:06:40+00:00 https://www.nrgoncology.org/Home/News/Post/making-the-best-of-the-worst-the-importance-of-having-a-positive-healthcare-team/ 2024-12-12T16:02:05+00:00 https://www.nrgoncology.org/Home/News/Post/testing-proton-craniospinal-radiation-therapy-for-patients-with-breast-or-non-small-cell-lung-cancer-leptomeningeal-metastasis-nrg-bn014/ 2024-12-12T16:06:38+00:00 https://www.nrgoncology.org/Home/News/Post/psc-continuing-education-sessions-at-nrg2025/ 2024-12-12T16:09:26+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-december-2024-newsletter/ 2024-12-12T16:12:27+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-suggests-the-addition-of-sbrt-to-systemic-therapy-improves-outcomes-for-select-patients-with-locally-advanced-hepatocellular-carcinoma/ 2024-12-19T16:01:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-theranostics-subcommittee-to-organization-new-leadership-members-for-ccdr-early-phase-trial-oversight-committees/ 2025-01-06T15:41:21+00:00 https://www.nrgoncology.org/Home/News/Post/common-errors-in-recist-v11-reporting/ 2025-01-12T23:00:58+00:00 https://www.nrgoncology.org/Home/News/Post/from-fear-to-advocacy-kimberly-williams-journey-as-a-cervivor-change-agent/ 2025-01-12T23:05:08+00:00 https://www.nrgoncology.org/Home/News/Post/adding-bmx-001-to-the-usual-chemoradiation-therapy-for-patients-with-head-and-neck-cancer-nrg-cc013/ 2025-01-12T23:08:59+00:00 https://www.nrgoncology.org/Home/News/Post/adding-cemiplimab-to-surgery-and-radiation-for-advanced-skin-cancer-nrg-hn014/ 2025-01-12T23:12:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-br008the-hero-trial-amendment-update/ 2025-01-12T23:14:57+00:00 https://www.nrgoncology.org/Home/News/Post/patient-reported-outcomes-compliance-improvement-semi-annual-recognition/ 2025-01-12T23:18:18+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-january-2025-newsletter/ 2025-01-12T23:21:47+00:00 https://www.nrgoncology.org/Home/News/Post/radiotherapy-with-cetuximab-may-be-superior-to-radiotherapy-alone-for-selected-patients-who-underwent-surgery-for-head-and-neck-cancer/ 2025-01-24T15:30:38+00:00 https://www.nrgoncology.org/Home/News/Post/february-is-cancer-prevention-month-steps-we-can-take-today-for-a-healthier-tomorrow/ 2025-02-17T16:07:04+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-opens-first-pragmatic-and-streamlined-trial-one-versus-two-years-of-maintenance-olaparib-for-patients-with-brca12-mutated-or-homologous-recombination-deficient-hrd-ovarian-cancer-nrg-gy036/ 2025-02-17T16:14:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2025-winter-meeting-wrap-up/ 2025-02-17T16:23:29+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-february-2025-newsletter/ 2025-02-17T16:25:24+00:00 https://www.nrgoncology.org/Home/News/Post/a-message-from-the-nctn-group-chairs-an-emphasis-on-the-importance-of-research-funding/ 2025-02-21T16:05:03+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-supports-radiotherapy-alone-following-radical-hysterectomy-should-remain-the-standard-of-care-for-early-stage-intermediate-risk-cervical-cancer/ 2025-03-14T13:40:01+00:00 https://www.nrgoncology.org/Home/News/Post/testing-ctdna-as-a-biomarker-for-adjuvant-therapy-intensity-in-colon-cancer-nrg-gi008-circulate-north-america-study/ 2025-03-18T13:22:51+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-march-2025/ 2025-03-18T13:44:39+00:00 https://www.nrgoncology.org/Home/News/Post/part-i-of-iv-part-series-informed-consent-discussion-documentation/ 2025-03-18T14:09:38+00:00 https://www.nrgoncology.org/Home/News/Post/head-neck-cancer-and-hpv-awareness-hearing-loss-after-cisplatin/ 2025-03-18T14:28:43+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-and-flatiron-health-announce-collaboration-to-leverage-leading-technology-to-drive-more-efficient-clinical-trials/ 2025-03-19T13:26:36+00:00 https://www.nrgoncology.org/Home/News/Post/rfa-for-the-nrg-early-career-mentorship-subcommittee/ 2025-04-01T19:16:19+00:00 https://www.nrgoncology.org/Home/News/Post/rfa-for-the-nrg-pac-chair/ 2025-04-07T18:23:47+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-sarcoma-subcommittee-to-organization-appoints-new-vice-chair-for-imaging-committee/ 2025-04-08T13:34:19+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-head-and-neck-cancer-portfolio/ 2025-04-14T18:01:32+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-activates-the-parrc-trial-for-high-grade-t1-bladder-cancer-nrg-gu014/ 2025-04-14T18:24:25+00:00 https://www.nrgoncology.org/Home/News/Post/bring-the-best-of-you-to-meet-the-best-of-science/ 2025-04-14T18:27:29+00:00 https://www.nrgoncology.org/Home/News/Post/part-i-of-iv-part-series-informed-consent-discussion-documentation-options/ 2025-04-14T18:31:23+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-april-2025/ 2025-04-14T18:34:55+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-committee-leaders-in-lung-cancer-and-imaging/ 2025-05-02T15:40:51+00:00 https://www.nrgoncology.org/Home/News/Post/leadership-changes-in-nrgs-protocol-support-committee-psc-and-psc-subcommittees/ 2025-05-06T16:32:07+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-may-2025/ 2025-05-12T16:41:45+00:00 https://www.nrgoncology.org/Home/News/Post/results-of-nrg-rtog-9813/ 2025-05-12T16:47:13+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc014-the-preempt-study/ 2025-05-12T16:49:36+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-quality-of-life-measures/ 2025-05-12T16:51:16+00:00 https://www.nrgoncology.org/Home/News/Post/more-than-medicine-why-cancer-research-needs-every-voice/ 2025-05-12T16:54:19+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-veterans-affairs-military-treatment-facility-subcommittee/ 2025-05-12T16:55:47+00:00 https://www.nrgoncology.org/Home/News/Post/introducing-the-nrg-oncology-investigator-career-development-committee/ 2025-05-12T16:57:15+00:00 https://www.nrgoncology.org/Home/News/Post/an-update-on-the-nrg-health-care-access-fellowship/ 2025-05-12T17:08:17+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-rfa-for-the-patient-advocate-committee-pcor-and-ovarian-cancer-representatives/ 2025-05-16T15:29:47+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-leaders-to-cancer-prevention-and-control-committee/ 2025-05-21T14:46:35+00:00 https://www.nrgoncology.org/Home/News/Post/rfa-for-the-nrg-pac-vice-chair/ 2025-06-03T19:15:24+00:00 https://www.nrgoncology.org/Home/News/Post/results-of-nrg-nsabp-b-51-rtog-1304/ 2025-06-05T14:24:00+00:00 https://www.nrgoncology.org/Home/News/Post/rfa-for-the-nrg-va-mtf-subcommittee-vice-chair/ 2025-06-12T17:01:11+00:00 https://www.nrgoncology.org/Home/News/Post/cancer-survivorship-month-honoring-the-resilience-of-all-affected-by-cancer/ 2025-06-16T16:09:52+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-study-tests-tailored-therapy-for-low-risk-endometrial-cancer-nrg-gy032/ 2025-06-16T16:27:23+00:00 https://www.nrgoncology.org/Home/News/Post/psc-at-the-nrg-2025-summer-meeting/ 2025-06-16T16:32:11+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-june-2025/ 2025-06-16T16:52:08+00:00 https://www.nrgoncology.org/Home/News/Post/information-about-the-psc-nrg-mentorship-program/ 2025-06-16T17:25:50+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-leaders-to-patient-advocate-committee-and-head-and-neck-cancer-committee/ 2025-06-26T13:39:05+00:00 https://www.nrgoncology.org/Home/News/Post/the-role-of-cra-and-ctn-committee-liaisons-in-nrg-oncology/ 2025-07-14T14:49:25+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-new-study-of-higher-dose-radiation-therapy-for-locally-advanced-pancreatic-cancer-nrg-gi011-lap100/ 2025-07-14T15:02:48+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-activates-the-heal-abc-study-harnessing-e-mindfulness-approaches-for-living-after-breast-cancer-nrg-cc015/ 2025-07-14T15:07:07+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-july-2025/ 2025-07-14T15:18:50+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-medical-oncologist-vice-chair-nrg-oncology-head-and-neck-cancer-committee/ 2025-07-23T15:23:11+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-medical-oncologist-vice-chair-nrg-oncology-lung-cancer-committee-1/ 2025-07-23T15:26:03+00:00 https://www.nrgoncology.org/Home/News/Post/dual-immune-checkpoint-inhibition-with-radiotherapy-does-not-improve-progression-free-survival-for-patients-with-newly-diagnosed-mgmt-unmethylated-glioblastoma/ 2025-08-13T13:23:17+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-appoints-new-ncorp-and-veteran-affairs-research-leadership/ 2025-08-13T14:25:08+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-august-2025/ 2025-08-13T18:15:43+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2025-summer-meeting-wrap-up/ 2025-08-13T18:21:25+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-a-message-of-support-from-the-new-pac-chair-tambre-leighn/ 2025-08-13T18:29:53+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-opens-new-archer-clinical-trial-nrg-gu015-testing-a-shorter-treatment-duration-of-radiation-therapy-for-muscle-invasive-bladder-cancer/ 2025-08-14T11:50:07+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-of-ancillary-projects-committee/ 2025-08-19T13:49:45+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-brain-tumor-committee/ 2025-08-19T13:53:26+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-breast-cancer-committee/ 2025-08-19T13:56:36+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-of-the-nrg-oncology-patient-centered-outcomes-research-pcor-committee/ 2025-08-19T13:59:45+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-translational-science-vice-chair-nrg-oncology-developmental-therapeutics-committee/ 2025-08-25T13:56:57+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-medical-oncology-committee/ 2025-08-25T13:58:20+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-translational-vice-chair-nrg-oncology-lung-cancer-committee/ 2025-08-25T13:59:39+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-of-the-nrg-oncology-translational-science-committee/ 2025-08-28T19:14:54+00:00 https://www.nrgoncology.org/Home/News/Post/annual-call-for-nrg-oncology-committee-member-applications/ 2025-09-05T16:30:28+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-two-positions-for-nrg-oncology-protocol-support-committee-psc-core-committee/ 2025-09-05T16:32:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-protocol-support-committee-psc-is-accepting-applications-for-general-committee-membership/ 2025-09-05T16:32:49+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-aims-to-move-the-needle-in-prostate-cancer-outcomes/ 2025-09-15T13:35:13+00:00 https://www.nrgoncology.org/Home/News/Post/new-nrg-oncology-trial-for-high-risk-locally-advanced-cervical-cancer-launching-soon/ 2025-09-15T13:36:32+00:00 https://www.nrgoncology.org/Home/News/Post/celebrating-progress-in-hereditary-cancer-prevention-the-sorock-trial/ 2025-09-15T13:38:14+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2025-summer-meeting-wrap-up-1/ 2025-09-15T13:45:43+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-september-2025/ 2025-09-15T13:49:29+00:00 https://www.nrgoncology.org/Home/News/Post/beyond-the-protocol-advocacy-in-gynecologic-cancer-care/ 2025-09-15T15:41:32+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-predict-rt-study-completes-patient-accrual-tests-individualized-concurrent-therapy-and-radiation-for-high-risk-prostate-cancer/ 2025-09-18T13:18:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-surgical-oncologist-vice-chair-nrg-oncology-brain-tumor-committee/ 2025-09-18T17:29:31+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-translational-science-vice-chair-nrg-oncology-brain-tumor-committee/ 2025-09-18T17:47:21+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-neuro-oncologistmedical-oncologist-vice-chair-nrg-oncology-brain-tumor-committee/ 2025-09-18T17:52:58+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-radiation-oncologist-vice-chair-nrg-oncology-breast-cancer-committee/ 2025-09-18T17:59:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-of-the-nrg-oncology-translational-science-committee/ 2025-09-18T18:01:53+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-of-the-protocol-operations-management-committee/ 2025-09-22T19:06:35+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-of-the-surgical-committee/ 2025-09-22T19:09:01+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-medical-oncologist-vice-chair-genitourinary-committee/ 2025-09-22T20:33:30+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-results-show-favorable-bowel-health-related-quality-of-life-outcomes-for-localized-immediate-risk-prostate-cancer-treated-with-stereotactic-body-radiation-therapy/ 2025-09-29T21:53:30+00:00 https://www.nrgoncology.org/Home/News/Post/patient-reported-outcome-analysis-of-nrg-oncology-trial-in-limited-stage-small-cell-lung-cancer-suggests-quality-of-life-benefit-with-twice-vs-once-daily-radiation/ 2025-09-30T22:46:41+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-analysis-shows-improvement-in-survival-outcomes-for-glioblastoma-patients-receiving-proton-therapy-trial-moves-to-phase-iii/ 2025-09-30T22:47:51+00:00 https://www.nrgoncology.org/Home/News/Post/an-update-on-current-nrg-oncology-breast-cancer-clinical-trials-october-2025/ 2025-10-14T15:45:30+00:00 https://www.nrgoncology.org/Home/News/Post/the-latest-updates-in-translational-science-at-nrg-oncology-october-2025/ 2025-10-14T15:48:19+00:00 https://www.nrgoncology.org/Home/News/Post/combomatch-eay191-n5-is-accruing-patients-with-recurrent-or-persistent-her2-gynecologic-cancers-and-other-solid-tumors/ 2025-10-14T15:50:46+00:00 https://www.nrgoncology.org/Home/News/Post/nci-rcr-and-aurora-integration/ 2025-10-14T15:53:47+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-updates-october-2025/ 2025-10-14T15:56:42+00:00 https://www.nrgoncology.org/Home/News/Post/webinar-nrg-gi004-s1610-amendment-9-overview/ 2025-10-24T15:40:08+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-understanding-consent-withdrawal/ 2025-10-24T15:56:51+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-of-the-publications-committee/ 2025-10-29T13:39:31+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-leadership-members-to-ancillary-projects-brain-tumor-breast-cancer-and-patient-advocate-committees/ 2025-10-29T15:20:35+00:00 https://www.nrgoncology.org/Home/News/Post/combining-radiotherapy-and-immunotherapy-in-patients-with-extensive-stage-small-cell-lung-cancer-nrg-lu007-the-raptor-trial-2/ 2025-11-13T03:04:50+00:00 https://www.nrgoncology.org/Home/News/Post/highlights-from-the-advanced-practice-practitioner-app-symposium-at-the-nrg-oncology-2025-summer-meeting/ 2025-11-13T03:07:32+00:00 https://www.nrgoncology.org/Home/News/Post/from-pilot-project-to-completed-trial-nrg-cc007cd-results-convey-importance-of-survivorship-care-planning-for-patients-with-prostate-cancer/ 2025-11-13T03:10:08+00:00 https://www.nrgoncology.org/Home/News/Post/patient-reported-outcomes-compliance-improvement-semi-annual-recognition-2/ 2025-11-13T03:11:48+00:00 https://www.nrgoncology.org/Home/News/Post/adding-stereotactic-body-radiation-therapy-to-immunotherapy-based-systemic-treatment-for-advanced-liver-cancer-nrg-gi012-the-helio-rt-study/ 2025-11-13T03:16:16+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-trial-of-sentinel-lymph-node-biopsy-for-patients-with-early-stage-oral-cavity-cancer-re-opens-to-phase-iii-nrg-hn006/ 2025-11-13T03:17:54+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-news-november-2025/ 2025-11-14T13:48:47+00:00 https://www.nrgoncology.org/Home/News/Post/good-clinical-practices-the-pillars-of-protocol-compliance-and-patient-safety/ 2025-11-14T13:50:18+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-leadership-members-to-developmental-therapeutics-patient-centered-outcomes-research-protocol-operations-management-head-and-neck-cancer-and-translational-science-committees/ 2025-11-24T15:15:00+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-of-the-ancillary-projects-committee/ 2025-12-04T15:39:33+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-of-the-protocol-operations-management-committee/ 2025-12-04T15:43:26+00:00 https://www.nrgoncology.org/Home/News/Post/psc-at-the-nrg-2026-winter-meeting/ 2025-12-15T15:22:40+00:00 https://www.nrgoncology.org/Home/News/Post/translating-molecular-insights-into-clinical-practice-recent-advances-from-nrg-oncology-trials/ 2025-12-15T16:01:10+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-news-december-2025/ 2025-12-15T16:20:09+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-patient-advocate-committee-call-for-committee-membership/ 2025-12-15T19:43:57+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-medical-physics-subcommittee/ 2025-12-22T18:54:53+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-of-the-nrg-oncology-patient-centered-outcomes-research-pcor-committee/ 2026-01-07T19:38:51+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-news-january-2026/ 2026-01-12T14:44:14+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-selects-health-care-access-hca-fellows-for-2026/ 2026-01-12T14:54:07+00:00 https://www.nrgoncology.org/Home/News/Post/psc-part-iii-of-iv-series-waivers-documentation-consent/ 2026-01-12T15:01:23+00:00 https://www.nrgoncology.org/Home/News/Post/research-strategy-committee-2025-the-year-in-review/ 2026-01-12T15:07:52+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-nrg-oncology-medical-oncology-committee/ 2026-01-13T16:21:18+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-of-the-investigator-career-development-icd-committee/ 2026-01-13T16:23:03+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-vice-chair-nrg-oncology-sarcoma-subcommittee/ 2026-01-20T14:34:34+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-leadership-members-to-brain-tumor-breast-cancer-genitourinary-cancer-lung-cancer-medical-oncology-medical-physics-protocol-operations-monitoring-publications-and-translat/ 2026-01-20T14:54:28+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-runsi-sen-jan2026/ 2026-01-27T19:08:22+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-representing-the-unrepresented-addressing-the-invisibility-phenomenon-of-adolescent-young-adults-aya-in-cancer-research/ 2026-01-27T19:08:29+00:00 https://www.nrgoncology.org/Home/News/Post/advocating-for-caregivers-during-national-family-caregiver-awareness-month/ 2026-01-27T19:09:04+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-names-dr-charles-geyer-as-associate-group-chair/ 2026-02-06T21:13:36+00:00 https://www.nrgoncology.org/Home/News/Post/cancer-prevention-month-forte-update-february-2026/ 2026-02-17T15:42:36+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-psc-2026-winter-meeting-wrap-up/ 2026-02-17T16:27:06+00:00 https://www.nrgoncology.org/Home/News/Post/greg-yothers-phd-to-retire-from-the-university-of-pittsburgh-and-the-nrg-oncology-sdmc/ 2026-02-17T16:31:29+00:00 https://www.nrgoncology.org/Home/News/Post/we-have-the-tools-preventing-cancer-before-it-begins/ 2026-02-17T16:51:14+00:00 https://www.nrgoncology.org/Home/News/Post/trial-results-update-the-commit-study-nrg-gi004-swog-s1610/ 2026-03-16T14:35:48+00:00 https://www.nrgoncology.org/Home/News/Post/forte-study-update-march-2026/ 2026-03-16T14:40:38+00:00 https://www.nrgoncology.org/Home/News/Post/adding-chemo-immunotherapy-or-chemotherapy-before-salvage-surgery-in-recurrent-or-persistent-squamous-cell-carcinoma-of-the-head-and-neck-nrg-hn015-the-neopolis-study/ 2026-03-16T14:48:51+00:00 https://www.nrgoncology.org/Home/News/Post/trials-in-progress-update-circulate-north-america-nrg-gi008-2/ 2026-03-16T15:17:52+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc011-reopening-after-temporary-hold-due-to-unprecedented-rapid-accrual/ 2026-03-16T15:43:15+00:00 https://www.nrgoncology.org/Home/News/Post/why-genetic-testing-saves-lives-lessons-from-a-lynch-syndrome-survivor/ 2026-03-16T16:21:47+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-adds-new-leadership-members-to-ancillary-projects-investigator-career-development-medical-oncology-patient-centered-outcomes-research-and-surgical-oncology-committees-sarcoma-subc/ 2026-03-30T13:40:40+00:00 https://www.nrgoncology.org/Home/News/Post/practice-defining-nrg-oncology-trial-finds-chemotherapy-followed-by-letrozole-is-the-standard-for-advanced-low-grade-serous-gynecologic-carcinoma/ 2026-04-10T17:45:59+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-oncology-seeks-to-fill-the-position-of-chair-nrg-oncology-pharmacy-subcommittee/ 2026-04-10T19:58:16+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-seeks-to-fill-translational-committee-vice-chair-positions-gynecologic-radiation-oncology/ 2026-04-10T20:07:26+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-hn016-concise-new-nrg-oncology-pragmatic-phase-3-trial-for-cisplatin-ineligible-locoregionally-advanced-head-neck-cancer-launching-soon/ 2026-04-15T07:00:57+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-working-group-spotlight-head-and-neck-patient-reported-outcomes-and-cost-effectiveness-working-group-proce/ 2026-04-15T07:00:22+00:00 https://www.nrgoncology.org/Home/News/Post/testing-temporally-modulated-pulsed-radiation-therapy-with-temozolomide-in-glioblastoma-nrg-cc017/ 2026-04-15T07:00:40+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-cc014-the-preempt-trial-successfully-completes-accrual/ 2026-04-15T07:00:08+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-part-v-of-v-series-understanding-informed-consent-and-assent-in-research/ 2026-04-15T07:00:56+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-from-bill-to-the-bench-how-legislative-advocacy-accelerates-cancer-care-and-research/ 2026-04-15T07:00:30+00:00 https://www.nrgoncology.org/Home/News/Post/nrg2026-winter-meeting-ncorp-bootcamp-recap/ 2026-04-15T07:00:34+00:00 https://www.nrgoncology.org/Home/News/Post/part-iv-of-v-series-recording-the-consent-process/ 2026-04-14T14:24:21+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-rtog-9512-uncovers-a-subset-of-radiation-resistant-tumors-driven-by-nrf2-mutations-providing-opportunities-for-rational-treatment-stratification-in-early-laryngeal-squamous-cell-carcinoma/ 2026-04-15T07:00:53+00:00 https://www.nrgoncology.org/Home/News/Post/forte-save-the-date-nrg-summer-meeting/ 2026-04-15T07:00:04+00:00 https://www.nrgoncology.org/Home/News/Post/annual-call-for-nrg-oncology-administrative-committee-member-applications-2/ 2026-04-20T18:19:00+00:00 https://www.nrgoncology.org/Home/News/Post/nrg-gy037-aims-to-advance-outcomes-in-high-risk-cervical-cancer/ 2026-05-12T07:00:26+00:00 https://www.nrgoncology.org/Home/News/Post/psc-column-record-retention-in-clinical-trials-where-are-they-now/ 2026-05-12T07:00:13+00:00 https://www.nrgoncology.org/Home/News/Post/advocate-angle-how-biobanking-can-empower-a-cancer-patient/ 2026-05-12T07:00:52+00:00 https://www.nrgoncology.org/Home/News/Post/forte-new-enrollment-record/ 2026-05-12T07:00:12+00:00 https://www.nrgoncology.org/Home/News/Post/reena-cecchini-phd-promoted-to-research-associate-professor-at-the-university-of-pittsburgh/ 2026-05-12T07:00:39+00:00 https://www.nrgoncology.org/Home/News/Post/in-memoriam-victor-g-vogel-md-mhs-facp/ 2026-05-12T07:00:27+00:00 https://www.nrgoncology.org/Home/News/Post/assessing-adaptive-radiotherapy-and-chemotherapy-for-muscle-invasive-bladder-cancer-nrg-gu015-the-archer-trial/ 2026-05-12T07:00:56+00:00 https://www.nrgoncology.org/Home/News/Post/testing-immunotherapy-with-radiation-therapy-for-patients-with-high-risk-t1-bladder-cancer-nrg-gu014-the-parrc-trial/ 2026-05-12T07:00:33+00:00